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KEVIN DALE BALLARD. Chromatographic and mass spectrometric 
analysis of bradykinin related arginyl peptides and other 
studies. (Under the direction of DANIEL R. KNAPP.) 
Dimethylpyrimidylornithyl-N-trifluoroethyl-O-TBDMS (DMPO-N-TFE-O-
TBDMS) polyaminoalcohol derivatives of arginyl peptides were evalu-
ated for their utility in peptide analysis by capillary gas chroma-
tography-mass spectrometry (GC-MS). These derivatives were hydro-
lytically stable and sufficiently volatile for capillary GC-MS 
analysis of low nanomole amounts of peptides as large as RPPGF. 
Complete amino acid sequence information was generated under elec-
tron impact ionization conditions, including several ions diagnostic 
for arginine residues, with molecular weight information imparted by 
+ + the [M-15] and [M-57] pair of ions characteristic of TBDMS deriva-
tives. Analysis of the sequential intermediate derivatives by 
FAB-MS facilitated optimization of problematic derivatization steps. 
As little as 20 picomoles of peptide could be detected by capillary 
GC-MS-selected ion monitoring, but problems with the reproducibility 
of the diborane reduction reaction limited its utility for quantita-
tive applications. DMPO-N,O-di-TBDMS polyaminoalcohol derivatives 
were found to provide similar structural information, with similar 
reproducibility problems at low levels. 
A procedure for selectively extracting arginyl peptides using 
immobilized phenylboronic acid columns exhibited limited binding 
with numerous co-extracted contaminants, and was judged to be 
impractical for biological samples. A reverse phase ion pairing 
liquid chromatographic procedure employing alternating ion pairing 
reagents successfully isolated 25-35 nanomole amounts of RPP, RPPG 
and RPPGF from spiked human urine. None of these peptides were 
detected at this level in unspiked urine. 
vi 
Further studies focussed on developing sensitive and reliable 
means of analyzing RPPGF as the DMPO-N-trifluoroacetyl-O-methyl 
ester derivative by direct insertion probe MS, thus avoiding the 
problematic diborane reduction reaction. Under electron impact 
ionization conditions, this derivative generated an unusually 
intense molecular ion suitable for low and high resolution selected 
ion monitoring. Molecular specificity was obtained by employing 
collisionally activated dissociation linked field selected reaction 
monitoring mass spectrometry, monitoring the formation of a specific 
fragment ion from the molecular ion in the first field free region 
of a double focussing mass spectrometer. With low level samples, 
the products at each stage of the derivatization were purified by 
reverse or normal phase HPLC. A 12 nanomole sample of RPPGF isolat-
ed from spiked human urine was successfully analyzed and definitive-
ly identified by these methods. 
vii 
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PART I 
CHROMATOGRAPHIC AND MASS SPECTROMETRIC ANALYSIS 
OF BRADYKININ RELATED ARGINYL PEPTIDES 
CHAPTER I 
INTRODUCTION 
The potent vasodilator peptide hormone bradykinin has a half-
life in blood on the order of 16-20 seconds (1,2); furthermore, 
bradykinin is degraded to the extent of 80-95% by a single passage 
through the lungs (1-5), and to varying degrees by other tissues 
(1,2,6). Thus, as Kaplan has pointed out (7), "direct determination 
of bradykinin as a measure of disease activity is usually unproduc-
tive.tI Considerable insight into the activity of the kallikrein-
kinin system under normal and pathologic conditions could be gained 
if specific end-product catabolic fragments of bradykinin were known 
and could be quantitated, since such fragments would reflect the 
total flux of bradykinin through the system. 
Bradykinin is a nonapeptide of sequence Arg-Pro-Pro-Gly-Phe-
Ser-Pro-Phe-Arg (single letter amino acid notation (8) RPPGFSPFR), 
and is well known to be degraded by two enzymes. Kininase I (EC 
3.4.12.7, carboxypeptidase N) is present in plasma and cleaves the 
9 C-terminal arginine residue from bradykinin to yield des-Arg -brady-
kinin (2,7,9). Kininase II (EC 3.4.15.1, angiotensin converting 
enzyme) is also present in plasma (10), and is highly concentrated 
in the lung (2,10) and other tissues (2). This enzyme, a dipeptidyl 
carboxypeptidase, can cleave bradykinin in two steps, first removing 
the C-terminal dipeptide FR, and then removing SP, ultimately 
yielding the pentapeptide RPPGF (2,7,9,10), which is not further 
cleaved by kininase II (7). 
9 This enzyme can also cleave des-Arg -
bradykinin (produced by kininase I) to yield the pentapeptide RPPGF 
plus SPF (7,9). 
2 
While the products of the individual enzyme-substrate reactions 
are well characterized, the catabolic fragments of bradykinin 
generated in vivo are virtually unknown, although a few studies have 
provided some valuable information in this area. In 1968 and 1970, 
Ryan and co-workers (3,4) demonstrated that bradykinin is essential-
1y quantitatively degraded by a single pass through the isolated rat 
lung, and gives rise to the peptide products PP, RPPG, and FR. Very 
little quantitative information was presented, other than to imply 
that PP and RPPG were generated in a 2:1 ratio. 
Also in 1970, Keiser and co-workers (11) studied the metabolism 
of [14C]-Pro2-bradykinin after intravenous infusion in man, and 
attempted to identify urinary metabolites. After 24 hours, urinary 
radioactivity accounted for 7-13% of the administered dose, plasma 
radioactivity accounted for 5%, with 7S-a5% unaccounted for. 
Calculating from the data presented, 5-5.5% of the administered 
radioactivity emerged in urine as the dipeptide PP after 2 hours, 
and approximately 1.5% emerged as unidentified "basic substances" in 
the same time period. A weak point in this study was the use of the 
intravenous infusion, in light of the high efficiency of the lung 
for degrading bradykinin. Since venous blood obligatorily passes 
through the lung before reaching other organ systems, the data 
generated in this study are more indicative of lung metabolism than 
whole body metabolism, which might be better represented after 
intra-aortic infusion, although this would be difficult to justify 
in man. 
3 
In 1985, Kaplan and co-workers (7,9) studied the degradation of 
bradykinin (500 ng/ml) in citrated plasma using HPLC techniques. 
After 15 minutes at 37°C, bradykinin, des-Arg9-bradykinin, and the 
tripeptide SPF were not detectable. The degradation products 
identified by HPLC retention times were free phenylalanine and a 
peak suggestive of the tetrapeptide RPPG. These authors suggested 
that a plasma carboxypeptidase is capable of removing C-terminal 
phenylalanine residues from des-Arg9-bradykinin, RPPGF, and SPF. 
Data conflicting with the above study were generated by Marceau 
and co-workers in 1981 (12). These authors studied the degradation 
of bradykinin (100 ~g/ml) in 20% heparinized plasma, and identified 
des-Arg9-bradykinin as the major degradation product by HPLC and 
bioassay. These discrepant findings may be due to either the 
incredibly high concentration of bradykinin studied, the use of 
diluted plasma, or the use of heparin rather than citrate as an 
anticoagulant. 
Judging from the above studies, the metabolism of bradykinin is 
complex and evidently involves other enzymes in addition to kinin-
ases I and II; the carboxypeptidase suggested by Kaplan (7) may be 
involved, as well as an aminopeptidase (kininase III) and a dipep-
tidyl aminopeptidase as suggested by Behal and coworkers (13,14). 
In none of the above studies were C-terminal or neutral peptides 
longer than a dipeptide identified. The N-terminal tetrapeptide 
RPPG was identified in both human plasma and the isolated rat lung 
preparation. The unidentified "basic substances n found by Keiser's 
group almost certainly contained the N-terminal RP sequence. The 
pentapeptide RPPGF is suggested as a likely catabolic fragment from 
enzymatic studies, since it is generated by two-step sequential 
degradation by kininase II, and also by the sequential action of 
kininase I followed by kininase II. 
4 
Extrapolating from the piecemeal evidence in the studies 
described above, a working hypothesis may be formed, stating that 
the metabolic products of the peptide hormone bradykinin include 
arginine-containing peptide fragments four or more amino acid 
residues in length, which retain much of the original amino acid 
sequence and thus are highly specific metabolites of bradykinin, and 
which when quantitated will serve as useful indicators of the 
activity of the kallikrein-kinin system as a whole. That this 
hypothesis has not been thoroughly tested in the past is not sur-
prising since reliable methods for isolating, identifying and 
quantitating small arginyl peptides at low levels have not existed. 
Due to these considerations, the overall goal of the studies 
described here was the elucidation of some of the chemical and 
instrumental means which may ultimately be necessary for analyzing 
small arginyl peptides with high chemical specificity, high sensi-
tivity and high reliability. These studies have focussed on the use 
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of the mass spectrometer as the final analytical tool in order to 
take advantage of the high sensitivity and specificity afforded by 
this instrument. Gas chromatography-mass spectrometry (GC-MS) of 
small peptides has long been recognized for its utility for generat-
ing amino acid sequence information (15-29), and its potential value 
for quantitating these compounds is beginning to become a reality 
(30,31). Quantitative capillary GC-MS methods using stable isotope 
labeled internal standards and selected ion monitoring techniques 
generically afford high sensitivity, high specificity, and excellent 
precision and accuracy (32,33). Significant advances in the 
quantitation of small peptides by these methods could be brought 
about by developing derivatives of peptides which possess good GC 
properties, generate intense ions at high mass in the mass spectrom-
eter, and ensure volatilization of the highly polar guanidino group 
of arginine residues. 
Two general methods have been developed over the past 27 years 
for volatilizing peptides for mass spectrometric amino acid sequence 
determination, namely the polyaminoalcohol derivatization procedure 
(15-23) and the permethylation procedure (25-29). Both of these 
methods have advantages, but in general the polyaminoalcohol deriva-
tives are more volatile, produce more reliable sequence information, 
and are more reliably formed (19,34). With both of these proce-
dures, arginine residues have presented a particular problem because 
of the high basicity and polarity of the guanidino group. The 
polyaminoalcohol scheme has traditionally included the conversion of 
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arginine residues to ornithine residues through hydrazinolysis prior 
to the chemical derivatization steps. However, hydrazinolysis can 
result in the loss of up to 60% of the original peptide through 
peptide bond cleavagej this type of loss would be an obvious impedi-
ment to the quantitative analysis of peptides, particularly in terms 
of overall sensitivity. In conjunction with the permethylation 
procedure, arginine residues have been successfully volatilized 
through derivatization with a-diketone reagents, such as 2,4-pen-
tanedione (acetylacetone), to form substituted or unsubstituted 
pyrimidyl-ornithine derivatives without associated peptide bond 
cleavage. This type of derivatization of arginine residues has not 
been used in the past with the polyaminoalcohol procedure, although 
the two are theoretically compatible. The diborane reduction step 
employed in the conversion of oligopeptides to polyaminoalcohols 
does not reduce heterocyclic aromatic ring systems (42), as exempli-
fied by its failure to reduce the side chain groups of tryptophan 
and histidine residues (43), and consequently should not reduce 
pyrimidyl-ornithine groups. Thus, the inclusion of this type of 
derivatization in the polyaminoalcohol scheme should ensure the 
volatilization of arginine-containing peptides without the risk of 
peptide bond cleavage during the derivatization reaction. 
Another aspect of the polyaminoalcohol scheme which could 
potentially be improved is its means of volatilizing hydroxy groups. 
The final step in the polyaminoalcohol scheme involves the deriva-
tization of hydroxy functions with the trimethylsilyl (TMS) group. 
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TMS derivatives are highly moisture sensitive and thus inherently 
unstable, and, while they give rise to characteristic [M-lSJ+ ions, 
these are usually of relatively low intensity. Studies employing 
tertiary-butyldimethylsilyl (TBDMS) derivatives have demonstrated 
that TBDMS derivatives are much more hydrolytically stable than TMS 
derivatives and, through loss of both a methyl and a tertiary-butyl 
group, TBDMS derivatives characteristically give rise to intense 
ions corresponding to [M-1S]+ and [M-57]+, which are very useful for 
both qualitative and quantitative work (33,44,45). The reagent 
N-methyl-N-(t-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) is 
potentially suitable for derivatizing polyaminoalcohols because of 
its high reactivity toward hydroxy groups and relatively low reac-
tivity toward secondary amines (46,47). 
The relatively new technique of fast atom bombardment mass 
spectrometry (FAB-MS) has proven very useful in many recent studies 
for ionizing and obtaining mass spectral data on nonvolatile com-
pounds such as underivatized and partially derivatized peptides. 
One of the goals of the present studies was to evaluate the utility 
of FAB-MS for documenting the success or failure of a series of 
sequential derivatization reactions such as those employed with the 
polyaminoalcohol scheme. It was anticipated that by analyzing the 
sequential derivatives after each reaction, problematic steps could 
be readily identified and remedial measures immediately taken. 
Because of the complex nature of most biological samples, it 
was anticipated that prepurification of the peptides of interest 
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would be necessary in order to reduce interference with the deriva-
tization reactions and the GC-MS analyses. Low and high resolution 
reverse phase liquid chromatography of peptides using perfluorinated 
alkanoic acids as lipophilic ion-pairing reagents are well known and 
widely used (48-53). Additionally, selective extraction of argin-
ine-containing peptides is possible (54,55). The reversible modifi-
cation of arginine residues of peptides with 1,2-cyclohexanedione 
(CHD) to form a vicinal diol derivative (54-56), with subsequent 
selective extraction of the modified peptides using immobilized 
boronic acid columns (54,55), has been described in the literature 
and has been used for the selective extraction of arginine-contain-
ing peptides for GC-MS analysis in conjunction with the permethyl-
ation method (55). 
The guanidino group of arginine residues reacts reversibly with 
CHD at pH 8-9 in borate buffers to form a vicinal diol derivative 
which is stable under acidic conditions and in borate buffers at pH 
8-9. At pH 7-9 in the absence of borate, the derivative spontane-
ously regenerates CHD and the guanidino group; this reversal process 
is quantitative in the presence of nucleophiles such as hydroxyl-
amine (54,56). Immobilized boronic acid groups interact selectively 
with vicinal dial groups at neutral or mildly alkaline pH to form 
covalent complexes, a process which can be reversed under acidic 
conditions (pH 1-2). Immobilized boronic acid columns can thus be 
used to selectively isolate CHD-modified arginyl peptides, with 
elution from the column at low pH, and with subsequent regeneration 
9 
of the arginine-containing peptide in hydroxylamine buffer at pH 7 
(56). In the published work, large proteins were first modified 
with CHD in the presence of borate, then dialyzed against dilute 
acetic acid to disrupt the borate complexes and desalt the CHD-
modified protein. CHD-modified peptides were then generated from 
the CHD-modified protein by partial hydrolysis, and the CHD-modified 
peptides subsequently isolated with immobilized boronic acid 
columns. Since the present studies dealt with small peptides rather 
than proteins, the dialysis step employed in the published work was 
not feasible, and other methods were therefore necessary to cleave 
the diol-borate complexes formed during the initial derivatization 
reaction and to desalt the sample. Toward this end, it was antici-
pated that acidification with a perfluorinated alkanoic acid fol-
lowed by ion pairing extraction using reverse phase cartridge 
columns would be a suitable procedure for hydrolyzing the diol-
borate complexes and desalting the CHD-modified peptides. 
In summary, these studies were undertaken with a view toward 
ultimately permitting the testing of the hypothesis that the activi-
ty of the kallikrein-kinin system may be estimated through quanti-
tation of putative bradykinin catabolites, a process which has been 
limited by the unavailability of sensitive, specific and reliable 
means for analyzing small arginyl peptides at low levels. Toward 
this end, the first specific goal was to evaluate the feasibility of 
incorporating the formation of volatile dimethylpyrimidylornithyl 
derivatives of arginyl peptides into the polyaminoalcohol 
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derivatization scheme for the capillary GC-MS analysis of peptides. 
A second related goal was to determine the feasibility of employing 
the TBDMS group for volatilizing the hydroxy functions of polyamino-
alcohols. The third primary goal envisioned at the outset of these 
studies was to develop efficient and reliable means of isolating 
bradykinin related arginyl peptides from complex biological matri-
ces, either by employing reverse phase ion pairing liquid chromato-
graphic procedures alone or in combination with an arginyl peptide 
selective extraction procedure which was to be developed. A fourth 
goal was to determine the utility of employing FAB-MS as a means of 
verifying sequential isolation procedures and derivatization 
reactions. An overriding goal was to develop mass spectrometric 
procedures for analyzing bradykinin related peptides with high 
reliability at low levels. Numerous problems were encountered 
during the course of these studies, the nature and solutions to 
which will be presented in subsequent chapters. 
In order to provide an overview of the detailed material which 
follows in subsequent chapters, the results of the present studies 
are summarized below. Initial studies with the simple dipeptide 
alanyl-alanine (AA) established the feasibility of employing the 
TBDMS group for derivatizing the hydroxy functions of polyamino-
alcohols. Subsequent studies with bradykinin related arginyl 
peptides demonstrated that dimethylpyrimidylornithyl-N-trifluoro-
ethyl-O-TBDMS polyaminoalcohol derivatives of these compounds may be 
formed and that these derivatives are sufficiently volatile for 
capillary GC-MS analysis of peptides as large as the pentapeptide 
RPPGF. Under repetitive scanning capillary GC-MS analysis condi-
tions, these derivatives generate complete amino acid sequence 
information in a fashion directly analogous to that of the well 
known N-trifluoroethyl-O-TMS polyaminoalcohols (17), with the 
additional molecular weight information provided by the easily 
recognized pair of ions corresponding to [M-lS]+ and [M-57]+ which 
is characteristic of TBDMS derivatives. These derivatives also 
11 
generate several ions diagnostic for arginine residues, and were 
found to be hydrolytically stable and useful for structural analysis 
of arginyl peptides at nanomole levels. During sensitivity studies 
with low level samples, as little as 20 pmoles of peptide could be 
detected by capillary GC-MS-SIM with good signal to noise ratio. 
Unfortunately, reproducibility problems with the derivatization 
chemistry, particularly the diborane reduction reaction, limited the 
utility of these derivatives for quantitative analysis of low level 
samples of arginyl peptides. The use of FAB-MS was particularly 
beneficial during these studies because it enabled the analysis of 
the sequential intermediate derivatives, and thus permitted ready 
identification of problematic derivatization steps. Some of the 
reaction conditions advocated in the most recently published version 
of the polyaminoalcohol scheme were not found to be optimal for the 
peptides employed in these studies. FAB-MS facilitated the identi-
fication of these problems so that corrective action could be taken. 
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Dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol deriva-
tives of arginyl peptides were briefly explored as a possible 
solution to some of the reproducibility problems encountered with 
the N-trifluoroethyl derivatives. The di-TBDMS derivatives were 
found to be suitable for capillary GC-MS analysis and to provide 
structural information similar to their N-trifluoroethyl counter-
parts. However, poor reproducibility was encountered with both the 
diborane reduction and the silylation reactions with these deriva-
tives even at high nanomole levels. 
A general procedure was developed for the selective extraction 
of arginyl peptides from aqueous matrices employing immobilized 
phenylboronic acid columns. This procedure was found to succ~ssful­
ly isolate standard arginyl peptides from aqueous buffers, and was 
demonstrated to be compatible with the derivatization procedures for 
capillary GC-MS analysis of these peptides. However, high perfor-
mance liquid chromatographic (HPLC) analysis of the extracts showed 
that numerous contaminating species were present in the extracts, 
and that the phenylboronic acid columns employed exhibit a very 
limited binding capacity. This procedure was therefore judged to be 
impractical for the isolation of arginyl peptides from biological 
matrices. 
A complex but higttly efficient procedure was developed for the 
isolation of the bradykinin related peptides RPP, RPPG and RPPGF 
from complex biological matrices, particularly urine. This proce-
dure was based on a combination of low and high resolution reverse 
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phase ion pairing liquid chromatography, with alternating ion 
pairing reagents. Low and high resolution FAB-MS demonstrated the 
successful isolation of 25-35 nmole amounts of these peptides from a 
spiked 20 ml human urine sample. 
Further studies focussed on developing sensitive and reliable 
means of analyzing the pentapeptide RPPGF, which was consistently 
the most problematic of the peptides studied. These experiments 
employed the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl 
ester derivative, which was sufficiently volatile for direct inser-
tion probe mass spectrometric analysis. The use of this derivative 
avoided the problematic diborane reduction reaction. Under electron 
impact ionization conditions, the molecular ion of this derivative 
was of unusually high intensity and was suitable for direct inser-
tion probe selected ion monitoring mass spectrometric analysis under 
both low and high resolution conditions. Further molecular speci-
ficity was obtained by employing direct insertion probe collision-
ally activated dissociation linked field selected reaction monitor-
ing mass spectrometry, monitoring the formation of a specific 
fragment ion from the molecular ion in the first field free region 
of a double focussing mass spectrometer. Success with low level 
samples was obtained through HPLC isolation of the sequential 
derivatives, with the final derivative isolated by normal phase 
HPLC. A sample of RPPGF isolated from spiked human urine was 




Acetonitrile, chloroform, methylene chloride and methanol were 
glass distilled UV grade (Burdick and Jackson Laboratories, Inc., 
Muskegan, MI). Water used for HPLC was analytical grade deionized, 
while water used for derivatization reactions was distilled in glass 
with reflux under argon and stored under argon at 4 °C. Trifluoro-
acetic acid (TFA, Fisher Scientific Co., Pittsburg, PA) was re-
distilled with reflux under nitrogen; heptafluorobutyric acid (HFBA, 
Aldrich Chemical Co., Milwaukee, WI) was used without further 
purification. Acetylacetone (Aldrich Gold Label), triethylamine 
(Fisher), pyridine (Fisher) and methyl trifluoroacetate (Alfa 
Products, Danvers, MA) were all redistilled in glass with reflux 
under argon. Acetylacetone, triethylamine and pyridine were stored 
under argon at -80 °C and warmed to room temperature just prior to 
use. Tetrahydrofuran was UV grade (Burdick and Jackson) stored over 
SA molecular sieves at room temperature (57). N-methyl-N-t-butyldi-
methylsilyltrifluoroacetamide (MTBSTFA, Regis 'Chemical Co., Morton 
Grove, IL) and N-methyl-bis(trifluoroacetamide) (MBTFA, Pierce 
Chemical Co., Rockford, 1L) were stored at 4 °C and warmed to room 
temperature prior to use. Methanolic Hel was freshly generated 
prior to use by slowly adding a stoichiometric amount of acetyl 
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chloride (Fisher) to methanol under argon at -10°C. Ethereal 
diazomethane was freshly generated prior to use from N-methyl-N-
nitroso-N1-nitroguanidine (Aldrich), 6N sodium hydroxide and diethyl 
ether (Fisher) using the apparatus and conditions described by Fales 
and co-workers (58). One molar diborane/tetrahydrofuran solution 
stabilized with 0.005 M sodium borohydride (Aldrich) was stored at 4 
°C under nitrogen. Cyclohexanedione (Aldrich), N-ethylmorpholine 
(Aldrich) and glycerol (Fisher) were reagent grade. 
The peptides Ala-Ala (AA, Sigma Chemical Co., St. Louis, MO), 
Arg-Phe (RF, Vega Biochemicals, Tucson, AZ), Arg-Pro-Pro (RPP, Serva 
Fine Biochemicals Inc., Westbury, NY), Arg-Pro-Pro-Gly (RPPG, Bachem 
Inc., Torrance, CA) and Arg-Pro-Pro-Gly-Phe (RPPGF, Serva) were 
stored dessicated at -20°C. These peptides were all of high purity 
with the exception of RPPG, the purity of which was estimated at 30% 
based upon HPLC and FAB-MS analysis. The amino acid L-(+)-arginine 
(Aldrich) was stored at room temperature. 
All other chemicals were reagent grade from commercial sources 
and were used without further purification. 
B. Glassware. 
Derivatization reactions were carried out in 1 or 2 ml Reacti-
lials (Pierce) with Teflon lined caps. All glassware which came in 
contact with analytical samples was silanized by immersion in a 2% 
(v/v) solution of dimethyldichlorosilane in toluene for 20 minutes, 
followed by thorough rinsing with absolute methanol (59 a). 
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c. Evaporation techniques. 
Excess derivatization reagents and solvents were removed either 
by evaporation under a stream of nitrogen or argon in a room temper-
ature water bath, or by evaporation under vacuum with centrifugation 
on a Speed-Vac Concentrator (Savant Instruments, Inc., Hicksville, 
NY). The Speed-Vac was equipped with a cold trap and a Precision 
Scientific Model 75 vacuum pump (Precision Scientific Co., Chicago, 
IL). 
D. High Performance Liquid Chromatography. 
High performance liquid chromatographic (HPLC) analyses were 
performed using a Waters Associates (Milford, MA) gradient elution 
HPLC system consisting of two Mode! 510 HPLC pumps a Model 680 
automated gradient controller, a Model U6K injector, and a Model 441 
absorbance detector. Chromatograms were recorded with a Fisher 
Recorda!l Series 5000 recorder. Reverse phase HPLC analyses were 
performed using a Vydac Protein and Peptides C1S 5 ~m column (25 cm 
X 4.6 mm i.d., The Sep/a/ra/tions Group, Hesperia, CA) equipped with 
a guard column. Normal phase HPLC analyses were performed using an 
Econosphere Silica 5 ~m column (25 cm X 4.6 mm i.d., Alltech Associ-
ates, Inc., Deerfield, IL). 
Two types of reverse phase analyses were performed during the 
course of these studies, depending upon whether trifluoroacetic acid 
(TFA) or heptafluorobutyric acid (HFBA) was used as the ion pairing 
reagent. Water and acetonitrile were the base solvents used in both 
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systems, with the ion pairing reagent at a concentration of 0.1% (by 
volume) in each solvent. For the TFA system, the column was equili-
brated with 0.1% TFA/water. At the time of injection, a linear 
gradient was initiated with 0.1% TFA/acetonitrile at a rate of 1% 
acetonitrile per minute. Similarly, for the HFBA system, the column 
was equilibrated with 0.1% HFBA/water, and a linear gradient with 
0.1% HFBA/acetonitrile at a rate of 2% acetonitrile per minute was 
initiated at the time of injection. For both systems, the flow rate 
was 1.5 ml/min throughout, with UV detection at 214 nm and a typical 
sensitivity setting of 0.5 absorbance units for a full scale deflec-
tion. 
Normal phase HPLC analyses were performed by equilibrating the 
column with chloroform, then at the time of injection initiating a 
linear methanol gradient to a final methanol concentration of 10i. 
over a twenty minute time period. Detection was with UV absorbance 
at 254 nm, with a typical sensitivity setting of 0.05 absorbance 
units for a full scale pen deflection. 
E. Mass Spectrometry and Gas ChromatographY-Mass Spectrometry. 
All mass spectrometric analyses performed during the course of 
these studies employed a Finnigan MAT 212 double focussing mass 
spectrometer. This instrument is of reverse Nier-Johnson geometry 
(the magnetic sector preceeds the electric sector), has a nominal 
accelerating voltage of 3 kV, and has a routine high resolution 
capability of 15-20,000. The mass spectrometer was interfaced to a 
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Finnigan Spectrosystem S3200 data system equipped with selected ion 
monitoring hardware for data acquisition during repetitive scanning 
and selected ion monitoring experiments. When appropriate, a Bell 
an Howell Model 525150 oscillographic recorder (Bell and Howell, 
Pasadena, CA) was used for the recording of mass spectral data. 
For fast atom bombardment mass spectrometric (FAB-MS) analyses, 
an Ion Tech FABI1NF saddle field fast atom gun (Ion Tech Ltd., 
Middlesex, England) powered by an Ion Tech BSO power supply was 
adapted to the MAT 212. Xenon gas was introduced into the FAB gun 
through a Granville-Phillips Variable Leak valve (Series 203, 
Granville-Phillips Co., Boulder, CO). The probe used for FAB-MS was 
fabricated in these laboratories, employing a 316 stainless steel 
brush finished probe tip (angle of incidence 60°) and an insulator 
fabricated from Kel-F. For a typical analysis, the probe tip was 
first coated with a thin layer of glycerol. Then, a small amount of 
the solid or oily analytical sample was removed from the sample vial 
using a clean stainless steel wand, and was mixed with the glycerol 
directly on the probe tip. The FAB probe was then introduced into 
the ion source, the FAB gun was turned on with xenon accelerated to 
6-8 kV, and several scans were recorded over the 15-1000 atomic mass 
unit (amu) range at a scan rate of 8 sec/decade. These techniques 
generally produced excellent results with very little sample con-
sumption. Ion source potentials were optimized while monitoring the 
m/z 277 ion of glycerol, and a mixture of poly(ethyleneglycol)s of 
average molecular weight 200, 400 and 600 (Aldrich) was used for 
routinely calibrating the mass spectrometer under FAB conditions. 
-6 
The typical ion source pressure was 5 x 10 torr, and the ion 
source was operated at room temperature. 
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A Varian 3700 gas chromatograph (Varian Associates, Inc., Palo 
Alto, CA) was interfaced to the MAT 212 for capillary gas chromato-
graphy-mass spectrometry (GC-MS) analyses. Columns used were fused 
silica DB-1 and DB-5 (0.25 rom i.d., 0.25 ~m film thickness, J&W 
Scientific, Inc., Rancho Cordova, CA) columns 4-30 m in length, with 
the outlet end introduced directly into the ion source of the mass 
spectrometer through a heated transfer line (290-320 °C). The gas 
chromatograph was modified to incorporate an on-column injector 
fabricated in these laboratories employing glass inserts purchased 
from J&W Scientific. For a typical analysis, 3-5 ~l of sample were 
slowly injected on-column in the cooled zone with the GC oven 
temperature 10-15 °C above the nominal boiling point of the highest-
boiling solvent component in the sample. The on-column injector was 
then lowered and. after solvent clearance. the GC oven temperature 
was programmed at a rate of 5-10 °C/min to a maximum of 325°C. 
Data collection was initiated at the moment of temperature program 
initiation. High purity helium (>99.95 %) was used as the carrier 
gas, with the capillary head pressure adjusted to give an average 
linear velocity of 45-55 em/sec at the upper GC oven temperatures 
(60). The ion source of the mass spectrometer was maintained at a 
temperature of 250°C. The mass spectrometer was operated in 
electron impact mode. with an electron energy of 70 eV and 1 rnA 
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electron emission. For all GC-MS analyses, the ion source poten-
tials were optimized while monitoring the m/z 207 GC bleed ion with 
the GC oven at or near the temperature of elution of the samples. 
Repetitive scanning GC-MS analyses were performed with the mass 
spectrometer operated at a resolution of 1,900-2,300 (50% peak 
height definition), scanning the 70-1000 amu range at a rate of 
3 sec/decade, with an interscan time of 600 msec. For selected ion 
monitoring experiments, the mass spectrometer was set at a resolu-
tion af 1,000-1,200 with a flat topped peak shape. The magnet was 
operated in current regulation mode for field strength stability, 
and was manually focussed to the center of the ion of interest using 
a standard sample as reference material. The secondary electron 
multiplier was operated at 2,200 V for high level samples and at 
2,800 V for low level samples. Selected ion monitoring data were 
collected using the SS200 data system at a rate of 5-10 intensity 
readings per second (each intensity reading was the average of 16 
individual samples). Perfluorokerosine (peR Inc., Gainesville, FL) 
was used to calibrate the mass spectrometer under electron impact 
conditions. 
Direct insertion probe mass spectrometric (DIP-MS) analyses 
were performed with the FAB gun removed from the MAT 212 and re-
placed with a lock valve to permit the introduction of the heated 
DIP. For all DIP-MS experiments, 2-6 ~l of dissolved sample were 
introduced into a 1.9 mm x 10 mm glass DIP sample vial. The DIP 
vial was placed into a 1 ml Reactivial, and solvents were removed 
21 
under vacuum with centrifugation on the Speed-Vac. This process was 
repeated if necessary to accumulate sufficient material in the DIP 
vial for analysis. The vial was then immediately inserted into the 
probe tip and introduced into the ion source of the mass spectrome-
ter at room temperature. After instrumental stabilization, data 
collection and probe heating were initiated. The mass spectrometer 
was operated in electron impact mode for all DIP-MS experiments, 
with an electron energy of 70 eV, an electron emission of 1 mA, and 
with the ion source temperature maintained at 250°C. 
Repetitive scanning data were obtained with the instrument set 
at a resolution of 1,900-2,300, scanning over the 100-1000 amu range 
at a scan rate of 3 sec/decade. The probe was heated at a rate of 
0.6-1.3 °C/sec during these experiments. 
Low resolution direct insertion probe selected ion monitoring 
analyses were performed with the mass spectrometer set at a resolu-
tion of 1,000-1200 with a flat topped peak shape. The magnet, 
operated in current regulation mode, was focussed manually to the 
center of the ion of interest using a standard sample as reference 
material. The analytical sample was run immediately thereafter. 
The probe was heated at a rate of 1.3-2 °C/sec during these 
experiments. 
For high resolution direct insertion probe selected ion moni-
toring experiments, the mass spectrometer was tuned to a resolution 
of 14-15,000. The magnet, operated in current regulation mode, was 
manually coarsely focussed to the region of the ion of interest 
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using a magnetic calibration table generated by the S5200 data 
system (CALIB routine) accurate to within 0.2 atomic mass units. 
Perfluorokerosene was introduced into the mass spectrometer as a 
reference sample, and the accelerating voltage was electrically 
jumped (MACQ routine using MISLRS microcode) to a perfluorokerosine 
ion slightly higher in mass than the ion of interest using a highly 
accurate electrical calibration table generated by the SS200 data 
system (ECAL routine). The magnet was then finely adjusted manually 
to focus the reference mass. Perfluorokerosine introduction was 
then stopped and the data system was set for selected ion monitoring 
of the ion of interest. The analytical sample was run immediately 
thereafter in order to avoid magnetic field strength drift, typical-
1y with a probe heating rate of 2°C/sec. 
Direct insertion probe collisionally activated dissociation 
selected reaction monitoring mass spectrometry (DIP-CAD-SRM-MS) 
experiments were performed with the mass spectrometer set at a 
resolution of 1,000-1200. Xenon gas was used for collisional 
activation in these experiments~ and was introduced into the region 
of the ion source and the first field free region of the mass spec-
trometer through a Granville-Phillips Variable Leak valve and a 2 m 
segment of 0.25 mm i.d. fused silica capillary tubing. Good results 
were obtained with the xenon flow adjusted to give an ion source 
-6 pressure of 6-8 x 10 torr. For these experiments, the linked 
field unit of the MAT 212 was operated in B/E mode to maintain a 
cons~ant relationship between the field strengths of the magnetic 
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and electric sectors. The magnet and the linked field unit were 
adjusted to focus the precursor ion of interest using a standard 
sample as reference material (this process determines the constant 
B/E to be used by the linked field unit). The linked field unit was 
then switched to "measure" to maintain the ratio B/E constant, and 
the magnet was refocused to the center of the fragment ion of 
interest using the standard sample as a reference. The analytical 
sample was. run immediately thereafter, with the data system operated 
in selected ion monitoring mode, and with the DIP heated at a rate 
of 2-3 °C/sec. 
F. Condensation of arginine residues with 2,4-pentanedione 
(acetylacetone) . 
For most experiments with arginyl peptides, the procedure 
described by Morris and co-workers (38) was used with little modifi-
cation. To the dry peptide sample (20 pmoles to 100 nmoles) were 
added 50 ~l of water, 100 ~l of absolute ethanol and 50 ~l of 
triethylamine. The sample-was capped under argon, vortexed and 
centrifuged. Under a flow of argon, 100 ~l of acetylacetone were 
added. The sample was again capped under argon, vortexed and heated 
at 100°C for four hours with occasional vortexing during heating. 
The sample was then allowed to cool and placed on the Speed-Vac to 
reduce the volume to less than 5 ~l of yellow oil. Water (250 ~l) 
and glacial acetic acid (25 ~l) were added, and the sample was 
vortexed and then heated at 100 °C for twelve minutes with 
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occasional vortexing during heating. The sample was allowed to cool 
and extracted three times with 500-700 ~l of diethyl ether, with 
centrifugation to ensure complete separation of layers. The organic 
layers were discarded, and the aqueous sample was placed on the 
Speed-Vac until the volume was reduced to dryness. The sample was 
suitable for FAB-MS analysis at this stage. 
G. Methylation of carboxylic acid groups with diazomethane. 
Methanol (250 ~l) was added to the dry sample, which was then 
capped under nitrogen, vortexed, sonicated 15 min and cooled to 
o °C. Freshly generated ethereal diazomethane (approximately 
500 ~l) was added, and the sample was vortexed and immediately 
placed on the Speed-Vac to remove excess diazomethane and solvents. 
The dry sample was suitable for FAB-MS analysis. 
H. Methylation of carboxylic acid groups with 3 M methanolic HCI. 
To the dry sample were added approximately 500 ~l of freshly 
generated anhydrous 3 M methanolic He!; the sample was then sonic-
ated for one hour with occasional vortexing. Methanol and excess 
HCl were removed by evaporation under a stream of nitrogen. Seven 
drops of methanol were added, and the sample was vortexed, centri-
fuged and evaporated to dryness on the Speed-Vac, after which the 
sample was suitable for FAB-MS analysis. 
I. Trifluoroacetylation of amino groups with methyl 
trifluoroacetate. 
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Peptides were trifluoroacetylated with methyl trifluoroacetate 
essentially according to the published procedure (17). To the dry 
sample were added 250 ~l of methanol, 20 ~l of triethylamine and 
250 ~l of methyl trifluoroacetate. The sample was capped under 
nitrogen, vortexed and allowed to stand overnight at room tempera-
ture in the dark. The sample was then placed on the Speed-Vac to 
remove excess derivatization reagents and solvents. At this stage 
the sample was suitable for FAB-MS analysis. 
J. Trifluoroacetylation of amino groups with N-methyl-bis(tri-
fluoroacetamide) (MBTFA). 
Anhydrous tetrahydrofuran (200 ~l) and N-methyl-bis(trifluoro-
acetamide) (MBTFA, 50 ~l) were added to the dry sample. The sample 
was then capped under nitrogen or argon, vortexed and heated at 
80°C for 30-50 minutes. The sample was then sonicated for 30 min-
utes to help ensure complete dissolution, and heated 30 more minutes 
at 80 °C, with occasional vortexing during both heating steps. The 
sample was then allowed to cool and evaporated to dryness on the 
Speed-Vac, after which the sample could be analyzed by FAB-MS. 
K. Reduction of amide and ester groups with diborane. 
Samples were reduced with diborane using the published proce-
dure (17) essentially without modification. The dry sample was 
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capped under nitrogen and cooled to 0 °C in an ice bath. One molar 
diborane-tetrahydrofuran solution (200 ~l) was added, and the sample 
was vortexed and heated at 90°C for 30 minutes, with occasional 
vortexing during heating. The sample was then cooled to 0 °C in an 
ice bath, and excess diborane was destroyed by the careful dropwise 
addition of methanol, during which operation vigorous bubbling 
occurred. After bubbling had ceased, solvents and trimethoxyborane 
were removed by evaporation on the Speed-Vac. Boroamine complexes 
were then decomposed by the addition of 1 M methanolic Hel (approxi-
mately 500 ~1), with heating at 90°C for 30 minutes. The sample 
was allowed to cool, evaporated to dryness on the Speed-Vac, and the 
boroamine decomposition process was repeated. 
In order to convert the resulting polyaminoalcohol hydrochlo-
ride salts to the free polyaminoalcohols, the dry sample was dis-
solved in 200 ~l of 25% (w/v) aqueous potassium carbonate and 
extracted three times with 200 ~l of methylene chloride. The sample 
was centrifuged to ensure complete separation of layers, and the 
organic layers (lower) were combined. To the aqueous layer were 
added 200 ~l of 120% (w/v) aqueous potassium carbonate plus 
50-100 mg solid potassium carbonate. The sample was then extracted 
three times with 400 ~l of methylene chloride, and the organic 
layers (upper) were combined with those from the first extraction 
process. The combined extract was then centrifuged to separate out 
any residual aqueous phase, and transferred to another clean sample 
- . 
vial, with care taken to avoid transferring any water droplets. The 
extract was then evaporated to dryness on the Speed-Vac. At this 
stage the sample was suitable for FAB-MS analysis. 
L. Silylation of hydroxy groups with N-methyl-N-t-butyldimethyl-
silyltrifluoroacetamide (MTBSTFA). 
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To the dry sample were added 65 ~l of pyridine and 35 ~l of 
MTBSTFA. The sample was then vortexed and heated at 80 °C for one 
hour, with occasional vortexing during heating. The sample was 
allowed to cool and evaporated to dryness on the Speed-Vac. The dry 
sample could be analyzed by FAB-MS at this stage. The sample was 
then redissolved under nitrogen with vortexing and sonication in an 
appropriate volume of pyridine (typically 10-100 ~l). The sample 
was then ready for GC-MS analysis. 
M. Feasibility of N-trifluoroethyl-O-TBDMS polyaminoalcohol 
derivatives. 
In order to explore the feasibility of forming and analyzing 
N-trifluoroethyl-O-TBDMS polyaminoalcohol derivatives of peptides, a 
series of samples of the simple dipeptide AA (0.4 - 1.2 mg) were 
methylated with ethereal diazomethane, trifluoroacetylated with 
methyl trifluoroacetate, reduced with diborane and silylated with 
MTBSTFA. Reactions were carried out as described above with the 
exception of the methylation reaction, which was performed in the 
follo~ing manner. The sample was first converted to the hydrochlo-
ride salt form by adding 500 ~l of 1 N methanolic Hel to the dry 
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peptide, vortexing and immediately evaporating the sample to dryness 
on the Speed-Vac. The sample was then dissolved in 250 ~l of 
methanol, and ethereal diazomethane was added until the yellow color 
of diazomethane persisted. The sample was then sonicated for 
30 minutes and evaporated to dryness on the Speed-Vac. 
Samples were anaylzed by FAB-MS after methylation, DIP-MS after 
trifluoroacetylation, FAB-MS after reduction, and by GC-MS after 
silylation. 
N. Compatibility of DMPO derivatives of arginyl residues with 
diborane reduction. 
The compatibility of the dimethylpyrimidyl ring system with the 
diborane reduction reaction was tested by converting arginine to 
dimethylpyrimidylornithine aminoalcohol at a semi-synthetic level in 
the following manner. Arginine (5 mg) was converted to dimethyl-
pyrimidylornithine through derivatization with acetylacetone as de-
scribed in section F above and analyzed by by FAB-MS. The sample 
was then sonicated in a mixture of methanol and ethereal diazometh-
ane until all solid dissolved and the yellow color of diazomethane 
persisted. Solvents and excess diazomethane were removed by evapo-
ration on the Speed-Vac, and the sample was analyzed by FAB-MS. The 
sample was then reduced with 800 ~l of 1 M diborane-tetrahydrofuran 
solution as described in section K above. The isolated product was 
analyzed by FAB-MS. 
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O. Trifluoroacetylation: methyl trifluoroacetate versus MBTFA. 
The efficiency of the trifluoroacetylation of the amino groups 
of arginyl peptides with methyl trifluoroacetate was tested using a 
1.2 ~mole sample of the dipeptide RF. The peptide was converted to 
the DMPO derivative by condensation with acetylacetone, then methyl-
ated with ethereal diazomethane. The resulting methyl ester was 
treated with methyl trifluoroacetate as described in section I 
above. After evaporation on the Speed-Vac, the sample was analyzed 
by FAB-MS. 
Further evaluation of the trifluoroacetylation of amino groups 
with methyl trifluoroacetate was accomplished by carrying a series 
of samples of RF (0.6 - 1.6 ~moles) through the entire derivatiza-
tion process (condensation with acetylacetone, methylation, tri-
fluoroacetylation with methyl trifluoroacetate, reduction and 
silylation), varying the trifluoroacetylation reaction time from 
twelve to thirty-six hours. The fully derivatized samples were 
analyzed by capillary GC-MS-SIM, monitoring m/z 408. 
The feasibility of employing METFA for trifluoroacetylating the 
amino groups of arginyl peptides was tested using a 300 nmole sample 
of RF. The dipeptide was converted to the DMPO derivative with 
acetylacetone and methylated with 3 M methanolic Hel. The sample 
was then treated with MBTFA using the procedure described in section 
J above. The dry sample was analyzed by FAB-MS. 
P. Verification of sequential derivatization reactions by FAB-MS 
and capillary GC-MS. 
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A series of samples (170 - 600 nmoles) of RE, RPP, RPPG, and 
RPPGF were carried through the entire derivatization process to 
convert them to the corresponding DMPO-N-TFE-O-TBDMS polyaminoalco-
hoI derivatives. Using the general procedures described above, each 
sample was condensed with acetylacetone, methylated with ethereal 
diazomethane, trifluoroacetylated with with MBTFA, reduced with 
diborane and silylated with MTBSTFA. At the end of each derivatiz-
ation step, each sample was analyzed BY FAB-MS to determine the 
success or failure of the sequential reactions. The fully deriva-
tized samples were analyzed by both FAB-MS and capillary GC-MS. 
Q. Methylation - ethereal diazomethane versus methanolic HCl. 
In order to evaluate the relative utility of ethereal diazo-
methane and methanolic Hel as methylating reagents within the 
overall derivatization process, the two reagents were compared in 
parallel experiments. Two mixtures, each containing RPP 
(27 nmoles), RPPG (12 nmoles), and RPPGF (17 nmoles) were carried 
through the entire derivatization process. One mixture was methyl-
ated with ethereal diazomethane, the other with 3 M methanolic Hel; 
otherwise the samples were treated identically (both were trifluoro-
acetylated with MBTFA). The fully derivatized samples were analyzed 
by capillary GC-MS-SIM, monitoring the m/z 358 ion common to the 
three derivatized peptides. 
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R. Sensitivity studies. 
Overall sensitivity limits for the analysis of arginyl peptides 
as DMPO-N-TFE-Q-TBDMS polyaminoalcohol derivatives by capillary 
GC-MS-SIM were evaluated using a series of sample mixtures contain-
ing from 20 pmoles to 27 nmoles of each of the peptides RPP, RPPG 
and RPPGF. The mixtures were treated with acetylacetone, 3 M 
methanolic HCI, MBTFA, diborane and MTBSTFA as described above. The 
mixtures were analyzed by capillary GC-MS-SIM, monitoring the 
m/z 358 ion common to the three derivatized peptides. 
s. DMPO-N,O-di-TBDMS polyaminoalcohol derivatives of arginyl 
peptides. 
A series of samples (50 - 250 nmoles) of the peptides RF, RPP 
and RPPG were condensed with acetylacetone and reduced with diborane 
as described above (no methylation or trifluoroacetylation). To the 
dry samples were added 50 ~l of acetonitrile and 25 ~l of MTBSTFA. 
The samples were capped under nitrogen and heated at 60°C for 
fifteen to thirty minutes. Samples of RF were analyzed by FAB-MS 
after each sequential reaction. All samples were analyzed by 
cap·il1ary GC-MS. 
T. Arginyl peptide selective extraction procedure. 
The following general procedure was developed for the selective 
extraction of arginyl peptides from aqueous matrices. Reverse phase 
cartridge columns were C1S Sep-Paks (Waters Associates), which were 
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charged with 10 ml of 80% acetonitrile/water/O.l% HFBA, and washed 
and equilibrated with 10 ml of 0.1% HFBA/water. Immobilized phenyl-
boronic acid (PBA) columns were Bond Elut PBA columns (Analytichem 
International, Harbor City, CA), which were washed with 5 ml of 
aqueous 1% N-ethylmorpholine buffer (NEM, pH 8.0 (55» followed by 
5 ml of 0.1% HFBA/water, then equilibrated with 5 ml of 1% NEM 
buffer. 
The sample was first desalted by rendering it 1 to 1.5% by 
volume in HFBA (enough to acidify the sample to pH 1-2, and at least 
1%), loading it onto a charged and washed CIS Sep-Pak, washing with 
10 ml of 0.1% HFBA/water to effect desalting, and eluting with 
2-3 ml of 80% acetonitrile/water/D.l% HFBA. The sample was then 
evaporated to dryness on the Speed-Vac and redissolved with sonica-
tion in 1 ml of nitrogen saturated 0.15 M 1,2-cyclohexanedione in 
aqueous 0.25 M sodium borate buffer (pH 8.7) (55). The reaction 
mixture was heated at 40°C for three hours to form the borate-com-
plexed dihydroxycyclohexyl derivatives of arginyl peptides. The 
sample was then allowed to cool and acidified to pH 1-2 with HFBA to 
hydrolyze the borate complexes. After 30-45 minutes at room temper-
ature, the sample was desalted with a CIa Sep-Pak as described above 
and evaporated to dryness on the Speed-Vac. The sample was then 
redissolved with sonication in 2-4 ml of 1% NEM buffer and loaded 
onto a PBA column. The column was washed with 5 ml of 1% NEM 
buffer, then eluted directly onto a CIS Sep-Pak with 5 ml of 
1% HFBA/water. The Sep-Pak was washed with 10 ml of 0.1% HFBA/water 
and the sample was eluted with 2-3 ml of 80% acetonitrile/wa-
ter/O.l% HFBA. The eluate was evaporated to dryness on the Speed-
Vac. 
Samples of RF and RPPG (250 nmoles) were extracted from phos-
phate buffered saline (PBS) using these methods and analyzed by 
FAB-MS. An RF sample so extracted was derivatized to form the 
DMPO-N,O-di-TBDMS polyaminoalcohol and analyzed by capillary 
GC-MS-SIM, monitoring m/z 176. 
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The arginyl peptide selective extraction procedure was further 
evaluated using a sample containing 175 - 250 nmoles of each of the 
peptides RPP, RPPG and RPPGF in PBS, and a blank sample of PBS. 
These two samples were carried through the extraction procedure, and 
the extracts were redissolved in 0.1% TFA/water and analyzed by 
reverse phase ion pairing HPLC using the acetonitrile/water/TFA 
system described above. 
u. Reverse phase ion pairing chromatographic isolation of RPP, 
RPPG and RPPGF. 
The following procedure was developed for the isolation of RPP, 
RPPG and RPPGF from complex biological matrices. The Sep-Pak 
extraction steps were perfromed using two C1S Sep-Paks connected in 
series through a short segment of silanized glass tubing to double 
the total binding capacity. The double Sep-Paks were charged with 
10 ml of 80% acetonitrile/water/O.l% HFBA and washed with 10 ml of 
0.1% HFBA/water. 
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The sample was rendered 1% by volume in HFBA, and the pH was 
checked to ensure that the buffer capacity of the sample was over-
come by the HFBA. The sample was then loaded onto a charged and 
washed double CIS Sep-Pak, washed with 10 ml of 0.1% HFBA/water, and 
eluted with 35 ml of water saturated with diethyl ether containing 
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1% HFBA. After the ether was removed by rotary evaporation, the 
eluate was again loaded onto a double CIS Sep-Pak and washed with 10 
ml of 0.1% HFBA/water. The double cartridge column was then eluted 
with 10 ml of 10% acetonitrile/water/O.l% HFBA, to yield fraction Al 
(the RPP and RPPG fraction). The double column was washed with 
10 ml of 18% acetonitrile/water/O.l% HFBA, and finally eluted with 
10 rnl of,25% acetonitrile/water/0.1% HFBA to yield fraction Bl (the 
RPPGF fraction). 
Fractions Al and Bl were evaporated under a stream of nitrogen 
to remove acetonitrile, lyophilized, redissolved with sonication in 
2 ml of 0.1% TFA/water and filtered through Acrodisc 13 CR (0.45 ~m, 
Gelman Sciences Inc., Ann Arbor, MI) filters. Each fraction was 
then chromatographed by reverse phase ion pairing HPLC using the 
acetonitrile/water/TFA system. The region of the chromatogram 
corresponding to RPP and RPPG was collected from fraction Al to 
yield fraction A2, and the region corresponding to RPPGF was col-
lected from fraction Bl to yield fraction B2. On a day-to-day 
basis, the appropriate regions of the chromatograms were located by 
co-injecting a small amount of the analytical samples with a known 
amount of the standard peptides. For sample collections, 200-650 ~l 
were injected per run. The individual collections from multiple 
chromatograms were pooled as fractions A2 and B2. 
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Fractions A2 and B2 were evaporated under a stream of nitrogen 
to remove acetonitrile, lyophilized, redissolved with sonication in 
10 ml of 0.1% HFBA/water, and filtered through Acrodisc 13 CR 
(0.45 ~m, Gelman) filters. The fractions were then rechromato-
graphed by reverse phase ion pairing HPLC using the acetonitrile/wa-
ter/HFBA system, with 0.5 to 1.8 ml injected for each run. The 
region of the chromatogram corresponding to RPP and RPPG was col-
lected from fraction A2 to yield fraction A3, and the region corre-
sponding to RPPGF was collected from fraction B2 to yield fraction 
B3. Again, collections from multiple chromatograms were pooled as 
fractions A3 and B3. Aliquots of these fractions were evaporated to 
dryness on the Speed-Vac for FAB-MS analysis. 
Each step in this isolation procedure was carefully evaluated 
using mixtures of standard peptides and human urine samples, both 
unspiked and spiked with known amounts of the standard peptides RF, 
RPP, RPPG and RPPGF. For urine samples, no more than 20 ml of urine 
were loaded onto a double CI8 Sep-Pak for the initial extraction 
step. For higher volume urine samples, mUltiple extractions were 
performed and the eluates pooled. Subsequently, proportionate 
aliquots of the eluate were loaded onto double Sep-Paks for the 
second extraction, so that the same number of extraction operations 
were performed during both steps. 
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For the final evaluation of this isolation procedure, a 100 ml 
sample of urine from a normal male human volunteer (25-35 year old 
non-smoker on no prescription or over-the-counter medications) was 
divided into 20 and 80 ml aliquots. To the 20 ml aliquot were added 
54 nmoles of RPP, 24 nmoles of RPPG and 35 nmoles of RPPGF. The 
80 ml aliquot was used as an unspiked control. Both samples were 
carried through the isolation procedure, and the final A3 and B3 
fractions from both samples were analyzed by FAB-MS under low and 
high resolution conditions. The B3 fraction from the spiked sample 
("RPPGF tt fraction) was also derivatized and analyzed by DIP-MS as 
described below. 
v. Derivatization of RPPGF for DIP-MS analysis. 
Using standard samples (10-120 ~g) of RPPGF, the following 
procedure was developed for generating the dimethylpyrimidylorn-
ithyl-N-trifluoroacetyl-O-methyl ester derivative of RPPGF in high 
yield and purity for DIP-MS analysis at fairly low levels. 
To the dry peptide were added 10 ~l of water, 20 ~l of ethanol 
and 10 ~l of triethylamine. The sample was capped under argon, 
vortexed and centrifuged. Acetylacetone (20 ~l) was added under a 
stream of argon, and the sample was vortexed and heated at 100 °c 
for one hour with occasional vortexing during heating. The sample 
was allowed to cool and evaporated to dryness on the Speed-Vac. 
Schiff's bases were hydrolyzed by adding 100 ~l of water and 10 ~l 
of glacial acetic acid to the sample and heating at 100 °C for 
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12 minutes with occasional vortexing. The sample was then allowed 
to cool and extracted three times with 200 ~l of diethyl ether. The 
aqueous sample was evaporated to dryness on the Speed-Vac, then 
redissolved with sonication in 250-500 ~l of 0.1% TFA/water. The 
sample was then chromatographed by reverse phase ion pairing HPLC 
using the acetonitrile/water/TFA system. The region of the chromat-
ogram corresponding to DMPO-RPPGF was collected and evaporated to 
dryness on the Speed-Vac. The sample was then treated with 
3 M methanolic Hel as described in section H above and, after 
evaporation to dryness, the sample was redissolved with sonication 
in 1 ml of 20% methanol/water/O.lio TFA. The sample was chromato-
graphed by reverse phase ion pairing HPLC using the acetonitrile/wa-
ter/TFA system, and the region of the chromatogram corresponding to 
DMPO-RPPGF-O-methyl ester was collected and evaporated to dryness on 
the Speed-Vac. Trifluoroacetylation was accomplished by adding 
250 ~l of chloroform and 50 ~l of MBTFA to the sample, vortexing and 
allowing it to stand at room temperature for one hour. The sample 
was evaporated to dryness on the Speed-Vac, redissolved with sonic-
ation in 250-500 ~l of chloroform and chromatographed by normal 
phase HPLC using the chloroform/methanol gradient system. The 
region of the chromatogram corresponding to DMPO-RPPGF-N-TFA-Q-
methyl ester was collected and evaporated to dryness on the Speed-
Vac. After redissolution in 50 ~l of chloroform, the sample was 
ready for DIP-MS analysis. 
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w. DIP-MS analysis of standard RPPGF. 
Standard samples (17-210 nmoles) of RPPGF were converted to the 
DMPO-N-TFA-Q-ME derivative as described in section V above. After 
redissolution in 50 ~l of chloroform, 3-12 ~l aliquots were analyzed 
by repetitive scanning DIP-MS. Low and high resolution DIP-MS-SIM 
analyses were accomplished with 6-18 ~l aliquots, monitoring m/z 746 
(746.336 for high resolution), the molecular ion. For DIP-CAD-
SRM-MS analyses, the mass spectrometer was set to monitor the 
reaction where an m/z 746 ion decomposes to form an m/z 429 ion in 
the first field-free region of the mass spectrometer, and 6-12 ~l 
aliquots were used for these analyses. 
x. DIP-MS analysis of RPPGF isolated from spiked human urine. 
One third of the "RPPGF tI HPLC fraction (fraction B3) from the 
human urine sample which was spiked with standard peptides 
(35 nmoles of RPPGF) was derivatized to form the DMPO-N-TFA-Q-ME 
derivative using the procedure described above. After redissolution 
iJ1..:~50 J.ll of chloroform, a 6 J.,Il aliquot was analyzed by low resolu-
tion (R=1,000-1,200) DIP-MS-SIM, monitoring m/z 746. A second 6 J.ll 
aliquot was analyzed by high resolution (R=14-15,OOO) DIP-MS-SIM, 
monitoring m/z 746.336. The sample (6 J.,ll) was then analyzed by 
CAD-DIP-MS-SRM, monitoring the reaction where an m/z 746 ion decom-
poses to form an m/z 429 ion in the first field-free region of the 
mass spectrometer. Finally, a 12 J.ll aliquot was analyzed by repeti-
tive scanning DIP-MS at a resolution of 1,900-2,300. 
CHAPTER III 
RESULTS 
A. Feasibility of Q-TBDMS polyaminoalcohol derivatives. 
The feasibility of incorporating O-t-butyldimethylsilylation 
into the overall polyaminoalcohol scheme for peptides was tested 
with the simple dipeptide AA. Mass spectral analyses of the sequen-
tial derivatives leading to the formation of the N-trifluoroethyl-O-
TBDMS polyarninoalcohol derivative of AA are presented in Figures 3.1 
through 3.4. 
The FAB mass spectrum of the methyl ester derivative of AA 
shown in Figure 3.1 demonstrates several features typical of FAB 
mass ~pectra (61). The sample has a nominal molecular weight of 174 
and is ionized under FAB conditions to yield a pseudomolecular ion 
+ ([M+H] ) at m/z 175. A series of glycerol clusters of the pseudo-
molecular ion appear at m/z 267, 359, 451, 543 and 635. Each ion in 
this series is incrementally 92 mass units (the molecular weight of 
glycerol) heavier than its predecessor, and the ions in the series 
are of successively decreasing intensity. Also frequently observed 
in FAB mass spectra is a protonated dimer of the analyte, which 
appears at m/z 349 in Figure 3.1. Most of the other prominent ions 
in this spectrum (m/z 93, 185, 277, 369, 461, 553 and 645) are 
background ions due to the glycerol matrix. The combination of an 
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Figure 3.1. Fast atom bombardment mass spectrum of the methyl ester 
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Figure 3.2. Direct insertion probe electron impact mass spectrum of 
the N-trifluoroacetyl-O-methyl ester derivative of alanyl-alanine. 
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Figure 3.3. Fast atom bombardment mass spectrum of the N-trifluoro-
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Figure 3.4. Electron impact mass spectrum of the N-trifluoroethyl-
O-TBDMS polyaminoalcohol derivative of alanyl-alanine from capillary 
GC-MS analysis. 
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cluster ions starting at m/z 267 (175 + 92), and an apparent proton-
ated dimer all form a body of evidence indicating that the analyte 
has a molecular weight of 174 (61). Similar features were observed 
in many of the FAB spectra obtained during these studies, several of 
which are presented below. The spectrum in Figure 3.1 provides 
strong evidence for the successful formation of the methyl ester of 
AA. 
A direct insertion probe electron impact mass spectrum of the 
N-trifluoroacetyl-O-methyl ester derivative of AA is presented in 
Figure 3.2. As is typical of electron impact mass spectra, the 
molecular ion is of low relative intensity. The fragmentation 
pattern is consistent with the expected structure of the derivative. 
The sample was highly volatile, requiring little or no probe heating 
to obtain a mass spectrum. 
The FAB mass spectrum of the N-trifluoroethyl polyaminoalcohol 
(free hydroxy group) derivative of AA (m.w. 214) is presented in 
Figure 3.3. The sample exhibits a prominent pseudomolecular ion at 
m/z 215, with the typical series of glycerol cluster ions. 
An electron impact mass spectrum of the N-trifluoroethyl-O-
TBDMS derivative of AA from repetitive scanning capillary GC-MS 
analysis is presented in Figure 3.4. The cleavage pattern evident 
in the mass spectrum is consistent with that of the well known 
N-trifluoroethyl-O-TMS polyaminoalcohols (17). Additionally, the 
+ spectrum exhibits the pair of ions corresponding to [M-15] and 
[M-57]+ as is characteristic of TBDMS derivatives. The nomenclature 
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used to indicate the ions useful for amino acid sequence determina-
tion (AI' A2 , etc.) in this and similar spectra below is that 
published by Carr and co-workers (17). The derivative was highly 
volatile and eluted from a 30 m DB-5 capillary column at 120°C with 
excellent GC properties. This sample was also analyzed by FAB-MS, 
and exhibited an intense pseudomolecular ion at m/z 329 (data not 
shown). These studies with AA indicated that volatile N-trifluoro-
ethyl-O-TBDMS polyaminoalcohol derivatives can be formed and have 
potential utility for GC-MS studies of peptides. 
B. Compatibility of DMPO derivatives and diborane reduction. 
The next question addressed during the course of these studies 
was whether dimethylpyrimidylornithyl derivatives of arginyl resi-
dues are compatible with diborane reduction, i.e whether the dimeth-
ylpyrimidyl ring system is resistant to diborane reduction as 
expected. In order to address this question, dimethylpyrimidyl-
ornithine methyl ester was prepared at a semi-synthetic level and 
treated with diborane using the procedure described by Carr and 
co-workers (17). The FAB mass spectrum of the methyl ester of 
dimethylpyrimidylornithine (m.w. 252) is presented in Figure 3.5. 
The spectrum exhibits a very intense pseudomolecular ion at m/z 253, 
with a glycerol cluster ion at m/z 345 and a protonated dimer at 
m/z 505. The spectrum also exhibits an ion at m/z 267 which proba-
bly represents an over-methylated product which will be discussed 
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Figure 3.6. Fast atom bombardment mass spectrum of dimethylpyrimi-
dylornithine aminoalcohol. 
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product isolated from the diborane reduction of dimethylpyrimi-
dylornithine methyl ester. The expected product, with the ester 
group fully reduced to an alcohol group and with the dimethyl-
pyrimidyl group unaffected, has a molecular weight of 224. The FAB 
mass spectrum is dominated by an extremely intense pseudomolecular 
ion at m/z 225, with the ionization of the glycerol matrix sup-
pressed. Further evidence indicating that the dimethylpyrimidyl 
group was not reduced by diborane is the presence of the fragment 
ions at m/z 124, 136, 176, and 190, proposed structures for which 
are presented in Figure 3.7. These ions were observed in all of the 
electron impact mass spectra of dimethylpyrimidylornithyl deriva-
tives of arginine and arginyl peptides as will be presented below, 
and in many of the FAB spectra, particularly those in which the 
pseudomolecular ion was very intense as in Figures 3.5 and 3.6. The 
presence of these ions in Figure 3.6 indicates the presence of an 
intact dimethylpyrimidyl group. Hence it was concluded that the 
dimethylpyrimidyl ring system is inherently resistant to diborane 
reduction under the conditions employed. 
c. Trifluoroacetylation: methyl trifluoroacetate versus MBTFA. 
In the most recently published version of the polyaminoalcohol 
derivatization scheme, methyl trifluoroacetate is used for tri-
fluoroacetylating the amino groups of peptides (17). However, this 
reagent was found to be inefficient for trifluoroacetylating the 
amino termini of the arginyl peptides (as the 
m/z 124 m/z 136 m/z 176 m/z 190 
Figure 3.7. Proposed structures for the ions of m/z 124, 136, 176 




dimethylpyrimidylornithyl derivatives) employed in these studies. 
Evidence to this effect is presented in Figure 3.8, which is the FAB 
mass spectrum of the product of the trifluoroacetylation of the 
dimethylpyrimidylornithyl-O-methyl ester derivative of RF with 
methyl trifluoroacetate. The free amino precursor has a molecular 
weight of 399, and that of the trifluoroacetylated product is 495. 
Pseudomolecular ions corresponding to both the precursor and the 
product are present in the FAB mass spectrum, indicating the incom-
pleteness of the reaction with methyl trifluoroacetate. Note that 
the relative intensities of pseudomolecular ions in FAB mass spectra 
are not necessarily correlated with the relative amounts present in 
the sample; the fact that two pseudomolecular ions are present an 
FAB mass spectrum simply indicates that both compounds are present 
in the sample. Further evidence suggesting the inefficiency of 
methyl trifluoroacetate for trifluoroacetylating these peptides was 
provided by a series of samples of RF which were carried through the 
entire derivatization process to yield the DMPO-N-TFE-O-TBDMS 
polyaminoalcohol derivative for capillary GC-MS analysis, with the 
trifluoroacetylation reaction time varied from twelve to thirty-six 
hours. Only those samples with prolonged trifluoroacetylation times 
ultimately yielded strong GC-MS signals (data not shown). This 
reaction inefficiency is not surprising in light of some work 
published by Steglich and Hinze in 1976 (62). These investigators 
studied the trifluoroacetylation of various amino acids with methyl 
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Figure 3.8. Fast atom bombardment mass spectrum of the dimethyl-
pyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of 
arginyl-phenylalanine (RF-DMPO-N-TFA-Q-ME), derivatized using methyl 
trifluoroacetate. 
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time varied from ten minutes to forty-eight hours, depending on the 
amino acid. That the reaction time would vary from peptide to 
peptide with this reagent is only to be expected. 
However, in the context of an already time consuming deriva-
tization process, a single step reaction time of 36-48 hours was 
clearly unacceptable. In order to circumvent this problem, a 
procedure was developed employing N-methyl-bis(trifluoroacetamide) 
(MBTFA) as a trifluoroacetylating reagent, with an overall reaction 
time of 90 minutes. Typical results with this procedure are pre-
sented in Figure 3.9, which is the FAB mass spectrum of the product 
of the trifluoroacetylation of DMPO-RF-O-methyl ester with MBTFA. 
The pseudomolecular ion corresponding to the trifluoroacetylated 
product is present and very intense at m/z 496, while that corre-
sponding to the precursor (m/z 400) is not significant compared to 
the background. This reagent consistently gave good results, and 
the procedure was further refined during subsequent studies as 
described below. 
D. Documentation of sequential derivatization reactions by FAB-MS. 
A series of FAB mass spectra documenting the sequential deriva-
tization reactions leading to the formation of the DMPO-N-TFE-Q-
TBDMS polyaminoalcohol derivative of RF are presented in Fig-
ures 3.10 through 3.14. Each spectrum in this series exhibits an 
intense pseudomolecular ion corresponding to the anticipated deriva-
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Figure 3.9. Fast atom bombardment mass spectrum of the dimethyl-
pyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of 
arginyl-phenylalanine (RF-DMPO-N-TFA-Q-ME), derivatized using MBTFA. 
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Figure 3.10. Fast atom bombardment mass spectrum of the dimethyl-
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Figure 3.11. Fast atom bombardment mass spectrum of the dimethyl-
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Figure 3.12. Fast atom bombardment mass spectrum of the dimethyl-
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Figure 3.13. Fast atom bombardment mass spectrum of the dimethyl-
pyrimidylornithyl-N-trifluoroethyl polyaminoalcohol derivative of 
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Figure 3.14. Fast atom bombardment mass spectrum of the dimethyl-
pyrimidylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol deriva-
tive of arginyl-phenylalanine (RF-DMPO-N-TFE-O-TBDMS polyamino-
alcohol). 
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glycerol cluster ion, and two spectra (Figures 3.10 and 3.11) show a 
protonated dimer. Fragment ions indicative of the dimethylpyrimi-
dylornithine side chain (m/z 124, 136 and 176) are intense in all 
except Figure 3.12. The m/z 190 fragment ion appears after the 
reduction step, lending credence to the structure proposed for this 
ion in Figure 3.7. If this ion were present in the FAB mass spectra 
of the non-reduced derivatives, this proposed structure would 
clearly be invalid. 
It should be noted that the spectra in Figures 3.10 
through 3.14 were obtained after each successive derivatization step 
was applied to a single 150 nmole sample of RF. This was made 
possible through the use of the technique where a small amount of 
the solid or oily sample was removed from the sample vial and mixed 
with glycerol directly on the FAB probe tip, leaving the majority of 
the sample for further chemical treatment or analysis. Serial 
spectra were successfully obtained using these techniques starting 
with as little as 15-25 nmoles of peptide sample and carrying 
through the entire derivatization sequence. By analyzing the 
sequential steps by FAB-MS in this fashion, if a particular reaction 
failed or was clearly inefficient, steps could immediately be taken 
to correct the problem (e.g. repurification of reagents, alteration 
of reaction conditions, etc.); otherwise, the existence of a problem 
would only have been learned after failure of a GC-MS analysis, with 
no indication as to which step was problematic. 
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An additional example of these analyses is presented in Fig-
ure 3.15, which shows the FAB mass spectrum of the DMPO-N-TFE 
polyaminoalcohol derivative of RPPGF (prior to silylation). The 
spectrum exhibits a prominent pseudomolecular ion corresponding to 
the expected derivative at m/z 649, as well as numerous higher mass 
ions which probably represent side reactions from the diborane 
reduction. Ions indicative of the dimethylpyrimidylornithine side 
chain are present at m/z 124, 136, 176 and 190. Additionally, two 
fragments from the highly favored cleavage of the polyamine backbone 
appear at m/z 358 and 372. Due to space considerations, spectra 
documenting the sequential derivatives of all of the peptides 
studied will not be presented. However, arginine and each of the 
peptides RPP, RPPG and RPPGF were successfully analyzed by FAB-MS 
after each step to document the sequential derivatives. 
E. Capillary GC-MS of arginyl peptides as DMPO-N-TFE-Q-TBDMS 
ployaminoalcohol derivatives. 
Electron impact mass spectra from repetitive scanning capillary 
GC-MS analyses of arginine, RF, RPP, RPPG and RPPGF as the DMPO-N-
TFE-Q-TBDMS polyaminoalcohol derivatives are presented in Fig-
ures 3.16 through 3.20. All of these derivatives exhibited excel-
lent gas chromatographic properties, with typical baseline to 
baseline peak widths of 6-8 seconds on DB-1 capillary columns. 
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Figure 3.15. Fast atom bombardment mass spectrum of the dimethyl-
pyrimidylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol deriva-
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Figure 3.16. Electron impact mass spectrum of N-trifluoroethyl-O-
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Figure 3.17. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivative of 
arginyl-phenylalanine (RF-DMPO-N-TFE-O-TBDMS polyaminoalcohol) from 
capillary GC-MS analysis. 
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Figure 3.18. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivative of 
arginyl-prolyl-proline (RPP-DMPO-N-TFE-O-TBDMS polyaminoalcohol) 
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Figure 3.19. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivative of 
arginyl-prolyl-prolyl-glycine (RPPG-DMPO-N-TFE-O-TBDMS polyamino-
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Figure 3.20. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N-trifluoroethyl-O-TBDMS polyaminoalcohol derivative of 
arginyl-prolyl-prolyl-glycyl-phenylalanine (RPPGF-DMPO-N-TFE-O-TBDMS 
polyaminoalcohol) from capillary GC-MS analysis. 
295°C for RF (30 m column), 300°C for RPP (30 m column), 310°C 
for RPPG (30 m column), and 320°C for RPPGF (5 m column). 
The electron impact spectrum of fully derivatized arginine 
presented in Figure 3.16 shows the series of fragment ions due to 
the dimethylpyrimidylornithine side chain at m/z 124, 136, 176 and 
190. The related fragment ions at m/z 150 and 164, which are 
evident in Figure 3.16, were not consistently observed in the 
electron impact mass spectra of the arginyl peptides. The ion at 
m/z 275 represents cleavage on the carboxy side of the original 
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a carbon, the typical cleavage pattern for derivatives of this type. 
Also noteworthy are the ions corresponding to [M-15]+ and [M-57]+ 
due to the loss of a methyl group and a t-butyl group from the TBDMS 
moiety, respectively. 
The cleavage patterns evident in the electron impact mass 
spectra of the fully derivatized arginyl peptides in Figures 3.17 
through 3.20 are directly analogous to those of the well known 
N-TFE-O-TMS polyaminoalcohols (17), with primary cleavages occurring 
on the carboxy side of the original a carbons of the polypeptide 
chains. Both A and Z series ions (17) are consistently observed in 
all of these spectra. Also consistently observed are the fragment 
ions at m/z 124, 136, 176, and 190, which collectively may be 
considered to be diagnostic for the dimethylpyrimidylornithine side 
chain. All of these spectra exhibit the pair of ions corresponding 
to [M-15]+ and [M-57]+ as is characteristic of TBDMS derivatives. 
These important ions form an easily recognizable pair which serves 
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as a punctuation mark for the mass spectrum, clearly denoting the 
molecular weight of the fully derivatized peptide. The molecular 
ions of all of these derivatives were detectable under selected ion 
monitoring conditions but were quite weak. The derivatized brady-
kinin related peptides RPP, RPPG and RPPGF all have m/z 358 (the A2 
ion) as the base peak in their mass spectra. This was fortuitous 
since it meant that all three peptides could be detected with good 
sensitivity and molecular specificity simply by monitoring m/z 358 
under capillary GC-MS-SIM conditions. 
A representative chromatogram resulting from the derivatization 
of a mixture of RPP, RPPG and RPPGF (17-27 nmoles of each) and 
analysis by capillary GC-MS-SIM is presented in Figure 3.21. The 
three compounds were well resolved from each other and from inter-
fering peaks on a 5 m DB-l capillary column, with excellent chrom-
atographic properties. The peak corresponding to RPP is offscale 
(>80 V), and those corresponding to RPPG and RPPGF are of succes-
sively decreasing intensity. This can be partially accounted for by 
the fact that the m/z 358 ion represents an incrementally smaller 
percentage of the total ionization of the sample as the length of 
the peptide increases. However, of greater importance is the 
probability that the total yield of the final derivative decreases 
as the length of the peptide chain increases, resulting in reduced 
overall sensitivity for the longer peptides. As the number of 











~.88 18188 1:5:88 281e8 2~lel 38:88 
Figure 3.21. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 358) of a mixture of RPP, RPPG and RPPGF. The 
amount injected r~presented approximately 400 ng of each peptide. 
and/or incomplete decomposition of the highly stable bora amine 
complexes formed during reduction increases. 
F. Methylation: ethereal diazomethane versus 3 M methanolic HCl. 
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When diazomethane was used as the methylating reagent in the 
derivatization process, overmethylated products were observed by 
FAB-MS (see Figures 3.5, 3.6, 3.8, and 3.11 through 3.14) and by 
capillary GC-MS. For instance, under GC-MS-SIM conditions (monitor-
ing m/z 358), RPPGF eluted as three well resolved peaks. In light 
of the high reactivity of diazomethane (63), this probably repre-
sents attack on the dimethylpyrimidyl ring system, although methyl-
ation of the amino terminus or amide nitrogen have not been ruled 
out (overmethylated products were also observed with AA). In 
contrast, overmethylated products were not observed when 3 M methan-
olic HCl was used as the methylating reagent, as in Figure 3.21, 
where all three peptides eluted as single peaks. In order to 
evaluate the effect of the choice of methylating reagent on overall 
sensitivity, identical mixtures of RPP, RPPG and RPPGF (17-27 nmoles 
of each) were derivatized for GC-MS-SIM analysis, with one mixture 
methylated with diazomethane and the other with 3 M methanolic HCl. 
The results of GC-MS-SIM analysis of the mixtures are presented in 
Table 3-I. Methanolic HCL is clearly the superior reagent for these 
molecules, both from the standpoint of fewer side reactions, and 
from that of a greater overall yield of the sought derivative, with 
TABLE 3-I 
METHYLATION: METHANOLIC HCL VERSUS ETHEREAL DIAZOMETHANE 
Peak signal intensities from capillary GC-MS-SIM analysis of 
mixtures of 17-27 nmoles each of RPP, RPPG and RPPGF 
Methanolic Hel Diazomethane 
Mixture peak signal peak signal 
component intensity (V) intensity (V) 
RPP 80 40 
RPPG 8.8 2.2 
RPPGF 1.9 not detected 
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attendant better overall sensitivity. Similar results were obtained 
with repeated experiments. 
G. Sensitivity studies with DMPO-N-TFE-O-TBDMS polyaminoalcohol 
derivatives. 
In order to evaluate the lower limits of detectability of 
these peptides by these methods, a series of mixtures containing 
from 20 pmoles to 27 nmoles of each of the peptides RPP, RPPG and 
RPPGF were derivatized and analyzed by capillary GC-MS-SIM, moni-
toring m/z 358. Some of the results of these studies are presented 
in Figures 3.22 and 3.23. Figure 3.22 shows the chromatogram 
resulting from the derivatization and analysis of 20 pmoles of each 
of the three peptides. The tripeptide RPP was detected with an 80:1 
signal to noise ratio, while RPPG and RPPGF were not detected. The 
chromatogram in Figure 3.23 resulted from the derivatization and 
analysis of 270 pmoles of RPP, 120 pmoles of RPPG and 175 pmoles of 
RPPGF. The peak corresponding to RPP was offscale, RPPG was detect-
ed with a 12:1 signal to noise ratio, and RPPGF was not detected. 
The lowest amount of the pentapeptide RPPGF that was derivatized and 
definitively detected by capillary GC-MS-SIM was 1.7 nmoles (data 
not shown). 
Unfortunately, the results depicted in Figures 3.22 and 3.23 
were not typical. These results were very difficult to reproduce, 
and the problem was traced to two primary sources. The first of 
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Figure 3.22. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 358) of a mixture of 20 pmoles of each of the 
peptides RPP, RPPG and RPPGF. The entire sample was injected. RPPG 
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Figure 3.23. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 358) of a mixture of 270 pmoles of RPP, 120 pmoles 
of RPPG and 175 pmoles of RPPGF. The entire sample was injected, 
and RPPGF was not detected. 
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column performance with repeated injection of low level samples. 
During the derivatization process, oily reaction by-products gradu-
ally accumulate, to the extent that the final fully derivatized 
sample may contain 1-2 ~l of oily contaminants. Assuming that the 
oil has a density of 1, this means that on a mass ratio basis, a 
sample of 10 ng of peptide will have a contaminant to analyte ratio 
of 10-20,000:1. In order to detect these low level samples, the 
entire sample was frequently injected, meaning that 1-2 mg of 
unknown contaminants were co-injected with the low level analyte. 
Such a contaminant load could easily destroy the performance of a 
capillary column, particularly when heated to 320°C, the elution 
temperature of the pentapeptide. Extensive washing of the columns 
with solvents followed by deactivation with 1,3-diphenyltetramethyl-
disilazane (64) did not restore column performance. Furthermore, 
deterioration of column performance occurred using both on-column 
and splitless-split injection methods, indicating that the problem-
atic contaminants have some degree of volatility. 
The second source identified for the observed reproducibility 
problems at low levels was the diborane reduction step of the 
derivatization process. The preceding three steps consisting of the 
condensation with acetylacetone, methylation with 3 M methanolic 
Hel, and trifluoroacetylation with MBTFA, all consistently yielded 
the sought products as demonstrated by FAB-MS. These three reac-
tions basically worked every time at both low and high levels. The 
reduction step, however, was quite variable in its yield of the 
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sought polyaminoalcohol below a level of about 15-25 nmoles of these 
peptides. The irreproducibility of this reaction was most pro-
nounced with the longer peptides. This is not surprising since the 
probability of incomplete reduction and unwanted side reactions 
increases as the number of peptide bonds increases. 
The net result of these (and possibly other) sources of irre-
producibility was that above a level of 15-25 nmoles, the DMPO-N-
TFE-O-TBDMS polyaminoalcohol derivatives of these peptides were 
formed and detected with good reproducibility, although the deriva-
tive yield varied with the longer peptides even at these levels. 
Below the 15 nmole level, reproducibility became a significant 
problem. 
H. DMPO-N,O-di-TBDMS polyaminoalcohol derivatives. 
In an effort to overcome some of the reproducibility problems 
at low levels with the polyaminoalcohol derivatives, particularly 
the problem of GC column deterioration, a brief study was undertaken 
to examine the feasibility of employing DMPO-N,O-di-TBDMS polyamino-
alcohol derivatives for the capillary GC-MS analysis of arginyl 
peptides. The procedure necessary for the formation of these 
derivatives eliminates two steps as compared to their N-trifluoro-
ethyl counterparts, namely the methylation and trifluoroacetylation 
steps. The trifluoroacetylation step could obviously be omitted, 
and since the methylation step was only employed to facilitate 
sample solubility in the triflouroacetylating reagents (17), this 
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step was omitted as well. Note that both ester groups and carbox-
ylic acid groups are reduced by diborane to an alcohol function, and 
in fact the reaction occurs much more readily with the free carbox-
ylic acid group than with the ester group (42). 
The peptides RF, RPP and RPPG were successfully converted to 
the DMPO-N,O-di-TBDMS polyaminoalcohol derivatives, and Figures 3.24 
through 3.26 present their electron impact mass spectra from repeti-
tive scanning capillary GC-MS analysis. Like their N-trifluoroethyl 
counterparts, these derivatives yield mass spectra which contain 
complete amino acid sequence information including both A and Z 
series ions, with the pair of ions corresponding to [M-15]+ and 
[M-57]+ present in each to clearly denote the molecular weights of 
the derivatives. The fragments indicative of the dimethylpyrimidyl-
ornithine side chain at m/z 136, 176 and 190 are present in these 
spectra. 
These derivatives showed considerable promise from the stand-
point of ultimate sensitivity. Figure 3.27 presents a chromatogram 
resulting from the injection of 80 pmoles of RPP as the DMPO-N,O-
di-TBDMS polyaminoalcohol derivative under capillary GC-MS-SIM 
conditions, monitoring m/z 390, the A2 ion. This chromatogram 
exhibits a 2000:1 signal to noise ratio. Similarly, an injection of 
1 pmole of RF yielded an excellent signal to noise ratio as depicted 
in Figure 3.28. Note that these samples were derivatized at the 
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Figure 3.24. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginyl-

























Figure 3.25. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginyl-
prolyl-proline (RPP-DMPO-N,O-di-TBDMS polyaminoalcohol) from capil-



















Figure 3.26. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N,O-di-TBDMS polyaminoalcohol derivative of arginyl-
prolyl-prolyl-glycine (RPPG-DMPO-N,O-di-TBDMS polyaminoalcohol) from 
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Figure 3.27. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 390) resulting from the injection of 80 pmoles of 
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Figure 3.28. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 176) resulting from the injection of 1 pmole of RF 
as the dimethylpyrimidylornithyl-N,O-di-TBDMS polyaminoalcohol 
derivative. 
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While these derivatives do show promise, reproducibility 
problems were encountered with them even at relatively high levels. 
The sought derivative of the pentapeptide RPPGF was not definitively 
identified during the course of these studies. In addition to 
reproducibility problems with the diborane reduction, the silylation 
reaction presented problems as well. With the N-trifluoroethyl 
derivatives, the silylation reaction could be carried out in pyri-
dine, which supresses the reaction of MTBSTFA with secondary amines 
(46). Unfortunately, this element of control was not possible with 
the N,O-di-TBDMS derivatives, since pyridine also supressed the 
silylation of the primary amine functions of these molecules. 
Hence, the reaction was carried using acetonitrile as a solvent. 
What was observed on several occasions was that the sought deriva-
tive was formed and existed for a short period of time (as little as 
fifteen minutes), then converted to a higher mass compound which may 
have been over-silylated. Residual boron-containing contaminants 
may have also participated in this conversion to an unknown high 
mass product. Because of these problems, these derivatives were not 
pursued further during these studies. 
I. Selective extraction of arginyl peptides. 
In order to explore the feasibility of selectively extracting 
arginyl peptides from aqueous matrices, arginyl peptides were 
treated with 1,2-cyclohexanedione and extracted using a combination 
of immobilized phenylboronic acid columns and CIS Sep-Paks. Samples 
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of RF and RPPG so extracted and analyzed by FAB-MS exhibited pseudo-
molecular ions corresponding to the dihydroxycyclohexyl derivatives, 
along with numerous contaminating species. Upon treatment with 
acetylacetone, the dihydroxycyclohexyl group was exchanged with 
acetylacetone to form the highly stable dimethylpyrimidylornithyl 
derivative, as was verified by FAB-MS. A sample of 300 nmoles of RF 
was extracted from phosphate buffered saline by these methods, then 
derivatized to form the DMPO-N,O-di-TBDMS polyaminoalcohol deriva-
tive and analyzed by capillary GC-MS-SIM, monitoring m/z 176. The 
resulting chromatogram is presented in Figure 3.29. Although this 
chromatogram indicates that the extraction and derivatization 
process are compatible, the intensity of the RF peak in Figure 3.29 
is very low for the amount of sample represented. Similar results 
were obtained with RPP. In order to determine whether this was due 
to a derivatization problem or limited binding capacity in the 
immobilized phenylboronic acid columns, a mixture containing 
175-300 nmoles of each of the peptides RPP, RPPG and RPPGF was 
extracted from phosphate buffered saline by these methods, and the 
extract was analyzed by reverse phase ion pairing HPLC. A blank 
sample of phosphate buffered saline was treated identically in a 
parallel experiment. The resulting HPLC chromatograms are presented 
in Figure 3.30. Two conclusions may be drawn from these virtually 
identical chromatograms. First, this is clearly not an interfer-
ence-free system, as numerous contaminants appear in both chromato-
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Figure 3.29. Capillary GC-MS selected ion monitoring chromatogram 
(monitoring m/z 176) of RF as the dimethylpyrimidylornithyl-N,O-di-
TBDMS polyaminoalcohol derivative, resulting from the extraction of 
RF from phosphate buffered saline using the arginyl peptide selec-
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Figure 3.30. Analytical reverse phase ion pa1r1ng HPLC chromato-
grams of extracts of phosphate buffered saline (upper trace) and a 
mixture of 175-300 nmoles of each of the peptides RPP, RPPG and 
RPPGF in phosphate buffered saline (lower trace). The extracts were 
obtained using the arginyl peptide selective extraction procedure. 
87 
level of sensitivity, if the extraction were quantitative, the 
peptides would have yielded peaks roughly half of a full scale 
deflection in height, and would have been obvious as compared to the 
blank control sample. From these studies it was concluded that the 
arginyl peptide selective extraction procedure, while workable with 
standard samples, is probably impractical for application to complex 
biological samples such as urine. With the limited binding capacity 
of the phenylboronic acid columns, the likelihood of interfering 
species in biological samples effectively eliminating the binding of 
the peptides of interest is very high. 
J. Reverse phase ion pairing liquid chromatographic isolation of 
RPP, RPPG and RPPGF. 
A procedure based entirely on ion pairing reverse phase liquid 
chromatography was developed for the isolation of the bradykinin 
related peptides RPP, RPPG and RPPGF from complex aqueous matrices, 
particularly urine. The procedure employs two reverse phase ion 
pairing extraction steps using CIS Sep-Pak cartridge columns, with 
selective elution of the peptides from the cartridge columns at each 
step, and two reverse phase ion pairing HPLC isolation steps. 
Throughout the procedure, advantage is taken of the differing 
characteristics of the ion pairing reagents heptafluorobutyric acid 
(HFBA) and trifluoroacetic acid (TFA). 
Experiments with standard samples demonstrated that the pep-
tides RPP, RPPG and RPPGF could be extracted from aqueous matrices 
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and desalted using a CIa Sep-Pak with HFBA as an ion pairing 
reagent. The peptides could then be eluted from the Sep-Pak using 
water saturated with diethyl ether as the eluting medium, leaving 
strongly lipophilic materials adhering to the Sep-Pak. After 
removal of diethyl ether, the peptides could be re-extracted with a 
CIS Sep-Pak with HFBA as the ion pairing reagent. The more polar 
peptides RPP and RPPG could then be eluted using 10% acetonitrile in 
water, followed by a wash with 18% acetonitrile in water, and 
finally the more lipophilic pentapeptide RPPGF could be eluted using 
25% acetonitrile in water, again leaving highly lipophilic materials 
adhering to the Sep-Pak. During the second extraction step, the 
sample is divided into two fractions: fraction Al contains RPP and 
RPPG, and fraction B1 contains RPPGF. 
Due to space considerations, the results of experiments with 
standard peptides in simple aqueous media will not be presented. 
Rather, the presented results will focus on experiments with urine 
samples, particularly a 20 ml sample of human urine to which was 
added 54 nmoles of RPP, 24 nmoles of RPPG and 35 nmoles of RPPGF 
(spiked urine sample). A blank (unspiked) urine sample was run in 
parallel as a control. 
An analytical HPLC chromatogram of the initial extract of a 
20 ml urine sample, eluted from a Sep-Pak with water saturated with 
diethyl ether, is presented in Figure 3.31. Even with selective 
elution, high levels of hundreds of compounds are co-eluted with the 
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Figure 3.31. Analytical reverse phase ion pa1r1ng HPLC chromatogram 
of the initial extract of a 20 ml human urine sample, selectively 
eluted from an ODS Sep-Pak with water saturated with diethyl ether. 
extraction step, with further refined selective elution using 
varying percentages of acetonitrile. 
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The next step in the isolation procedure is further purifica-
tion of fractions Al and BI by reverse phase ion pairing HPLC, using 
TFA as the ion pairing reagent. Analytical HPLC chromatograms of 
the Al and BI fractions from the spiked urine sample on the TFA 
system are presented in Figures 3.32 and 3.33 respectively. Peptide 
components in the samples should be affected by the nature of the 
ion pairing reagent to a greater degree than non-peptide components. 
Since TFA is a much less lipophilic ion pairing reagent than HFBA 
(52), by changing the ion pairing reagent from HFBA in the extrac-
tion steps to TFA in the first HPLC step, the elution positions of 
the peptides of interest are shifted toward the earlier portions of 
the chromatograms, with non-peptide lipophilic material eluting 
later. The indicated regions of the chromatograms were collected 
under semi-preparative conditions to yield fractions A2 and B2. 
This required multiple injections of both samples in order to 
collect all of the material. 
The final step in the isolation procedure is reverse phase ion 
pairing HPLC of fractions A2 and B2 using the HFBA system. Analyt-
ical HPLC chromatograms of these fractions from the spiked urine 
sample are presented in Figures 3.34 and 3.35. The large baseline 
shift evident in these chromatograms is an artifact due to the HFBA 
in the system. The peptides of interest are shifted toward the 
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Figure 3.32. Analytical reverse phase ion pairing HPLC chromatogram 
(TFA system) of the Al fraction from a spiked urine sample (20 ml 
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles 
of RPPG and 35 nmoles of RPPGF). The indicated region (RPP and RPPG 
region) was collected under semi-preparative conditions to yield 
fraction A2. 








Figure 3.33. Analytical reverse phase ion pairing HPLC chromatogram 
(TFA system) of the Bl fraction from a spiked urine sample (20 ml 
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles 
of RPPG and 35 nmoles of RPPGF). The indicated region (RPPGF 
. region) was collected under semi-preparative conditions to yield 
fraction B2. 
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Figure 3.34. Analytical reverse phase ion pa1r1ng HPLC chromatogram 
(HFBA system) of the A2 fraction from a spiked urine sample (20 ml 
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles 
of RPPG and 35 nmoles of RPPGF). The indicated region (RPP and RPPG 
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Figure 3.35. Analytical reverse phase ion pairing HPLC chromatogram 
(HFBA system) of the B2 fraction from a spiked urine sample (20 ml 
sample of human urine to which was added 54 nmoles of RPP, 24 nmoles 
of RPPG and 35 nmoles of RPPGF). The indicated region (RPPGF 
region) was collected under semi-preparative conditions to yield 
fraction A3. 
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in the samples due to the use of HFBA as the ion pairing reagent. 
The indicated regions were collected from multiple chromatograms to 
yield fractions A3 and B3. 
K. FAB-MS analysis of RPP, RPPG and RPPGF isolated from spiked 
human urine. 
The FAB mass spectrum of fraction A3 isolated from the spiked 
urine sample is presented in Figure 3.36. For the sake of clarity, 
only the portion of the spectrum encompassing the ions of interest 
is displayed. The molecular weights of RPP and RPPG are 368 and 
425, respectively, and pseudomolecular ions corresponding to each of 
these peptides are present in the spectrum at m/z 369 and 426. 
Fortuitously, glycerol ionization was supressed with this sample, 
which enabled the visualization of the pseudomolecular ion corre-
sponding to RPP without interference from the m/z 369 background ion 
due to the glycerol matrix. Despite four successive steps of 
purification, numerous other species are present in this sample. 
Similar contaminant ions were in the blank urine sample as well, and 
ions at m/z 369 and 426 were not significant compared to background 
in the blank urine sample. While the ions corresponding to RPP and 
RPPG were not the most intense in this region of the spectrum in 
Figure 3.36, they were nevertheless reasonably intense for the 
amount of material represented in the spectrum. In fact, these ions 
were sufficiently intense to permit their visualization under FAB 
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Figure 3.36. Fast atom bombardment mass spectrum of the A3 fraction 
(RPP and RPPG fraction) from a spiked urine sample (20 ml sample of 
human urine to which was added 54 nmoles of RPP, 24 nmoles of RPPG 
and 35 nmoles of RPPGF). 
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characterize the nature of the m/z 369 and 426 ions in this sample, 
both ions were scanned at a resolution of 6-7,000 using the oscillo-
graphic recorder in order to visualize the peak profiles. Then, the 
authentic peptides were added to the glycerol-solvated sample, and 
these ions were re-scanned. The results of these scans are present-
ed in Figure 3.37. In both instances, the ion of interest increased 
in intensity while maintaining the peak profile of a single peak, 
rather than appearing as a doublet in the presence of the authentic 
peptides. These results indicate that the isolated materials have 
elemental compositions consistent with RPP and RPPG. 
Figure 3.38 presents the FAB mass spectrum of the B3 fraction 
isolated from the spiked urine sample. The pseudomolecular ion 
corresponding to RPPGF is quite intense at m/z 573. Again, numerous 
unknown species are present in the sample despite four steps of 
purification. This sample was not analyzed by FAB-MS under high 
resolution conditions. Rather, this sample was derivatized and 
analyzed by DIP-MS methods as described below. 
L. Derivatization and DIP-MS analysis of standard RPPGF. 
Since the pentapeptide RPPGF was consistently the most diffi-
cult to analyze of the peptides employed in these studies, efforts 
were directed toward developing sensitive, specific and reliable 
methodology for analyzing this peptide at reasonably low levels. 
Toward this end, DIP-MS methods were developed employing the dimeth-
ylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester (DMPO-N-TFA-
98 
m/z 369 m/z 426 
Figure 3.37. High resolution (R=6-7,OOO) fast atom bombardment mass 
spectral analysis of the pseudomolecular ion regions corresponding 
to RPP (m/z 369) and RPPG (m/z 426) of fraction A3 from the skiked 
urine sample. The traces show the pseudomolecular ion regions 
before (lower) and after (upper) the addition of authentic RPP and 
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Figure 3.38. Fast atom bombardment mass spectrum of the B3 fraction 
(RPPGF fraction) from a spiked urine sample (20 ml sample of human 
urine to which was added 54 nmoles of RPP, 24 nmoles of RPPG and 
35 nmoles of RPPGF). 
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O-ME) derivative of RPPGF. Unfortunately~ this derivative possesses 
insufficient volatility for capillary GC-MS analysis~ but it is 
sufficiently volatile for DIP-MS, giving peak signal intensity with 
the direct insertion probe tip at a temperature of approximately 
250 °C~ with the ion source pressure maintained at approximately 
-7 -6 10 -10 torr. Figure 3.39 presents an electron impact mass 
spectrum of RPPGF as the DMPO-N-TFA-Q-ME derivative from repetitive 
scanning DIP-MS analysis. The spectrum exhibits fragment ions 
consistent with the expected structure of the derivative, including 
the series of ions diagnostic for the dimethylpyrimidylornithine 
side chain, and ions representing cleavage on both sides of the 
carbonyl groups of all four peptide bonds. Most notably, the 
spectrum exhibits a surprisingly intense molecular ion at m/z 746, 
roughly 20% as intense as the base peak in the spectrum, which is 
quite unusual for an electron impact mass spectrum. This intense 
molecular ion was suitable for direct insertion probe selected ion 
monitoring mass spectrometric analysis under both low (R=1,900-
2,300) and high (R=14-15,OOO) resolution conditions as demonstrated 
in Figures 3.40 and 3.41, respectively. Unfortunately, DIP-MS 
methods suffer a loss of molecular specificity as compared to 
capillary GC-MS methods. In order to compensate for this loss of 
specificity, methods were developed employing direct insertion probe 
col1isionally activated dissociation selected reaction monitoring 
mass spectrometry (DIP-CAD-SRM-MS) for the assay. The reaction 
wherein an m/z 746 ion decomposes to form an m/z 429 ion in the 
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Figure 3.39. Electron impact mass spectrum of RPPGF as the dimeth-
ylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative 
(RPPGF-DMPO-N-TFA-O-ME) from repetitive scanning DIP-MS analysis. 
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Figure 3.40. Low resolution (R=1,900-2,300) direct insertion probe 
selected ion monitoring trace (monitoring m/z 746) of approximately 
1 nmole of RPPGF as the dimethylpyrimidylornithyl-N-trifluoro-
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Figure 3.41. High resolution (R=14-15,OOO) direct insertion probe 
selected ion monitoring trace (monitoring m/z 746) of approximately 
900 pmoles of RPPGF as the dimethylpyrimidylornithyl-N-trifluoro-
acetyl-O-methyl ester derivative (RPPGF-DMPO-N-TFA-Q-ME). 
first field free region of the mass spectrometer was arbitrarily 
chosen for these analyses (see Figure 3.39). Figure 3.42 presents 
an exemplary DIP-CAD-SRM-MS analysis of standard RPPGF. 
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The results presented in Figures 3.40 through 3.42 were ob-
tained using samples derivatized at the 175 nmole level, with small 
aliquots removed for analysis. Initial efforts to reproduce these 
results results using lower level samples (e.g. 10-20 nmoles) 
failed, with little or no signal for the molecular ion of the 
derivative detected by DIP-MS-SIM. However, after the attempted 
DIP-MS analyses, relatively large amounts of brown, obviously 
decomposed material were observed in the DIP sample vials. From 
this, coupled with the fact that the presence of the sought deriva-
tive in the samples could be demonstrated by FAB-MS, it was conclud-
ed that accumulated reaction by-products from the serial derivatiz-
ation steps were probably reacting with the derivative under the 
heating conditions of DIP-MS, thus preventing the detection of the 
derivative. 
The obvious solution to this problem was separation of the 
sought derivative from the problematic contaminants. Toward this 
end, HPLC isolation of the successive derivatives was incorporated 
into the overall process, with the final derivative isolated by 
normal phase HPLC. Experiments with 17 nmole samples of RPPGF 
demonstrated that the DMPO-N-TFA-O-ME could be formed, isolated and 
successfully analyzed by DIP-MS using these methods. Due to space 
considerations, these experiments with lower levels of standard 
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Figure 3.42. Direct insertion probe collisionally activated disso-
ciation linked field selected reaction monitoring mass spectrometric 
analysis of approximately 200 pmoles of RPPGF as the dimethylpyrimi-
dylornithyl-N-trifluoroacetyl-O-methyl ester derivative (RPPGF-DMPO-
N-TFA-O-ME). The formation of an m/z 429 fragment ion from an 
m/z 746 precursor ion was monitored. 
RPPGF will not be presented. The results with the B3 ("RPPGF") 
fraction isolated from spiked human urine are presented below. 
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An additional benefit of incorporating HPLC into the deriva-
tization process was that it permitted visualization and quantita-
tive estimation of the precursor, product, and some of the reaction 
by-products of each of the three derivatization steps. With the aid 
of HPLC, the methods used in the acetylacetone condensation and 
trifluoroacetylation steps were further optimized to maximize the 
yield of the sought derivatives. The methylation reaction consis-
tently yielded 90% or more of the sought methyl ester and was not 
further opitmized. 
M. Derivatization and DIP-MS analysis of RPPGF isolated from 
spiked human urine. 
One third of fraction B3 from the spiked human urine sample 
(representing approximately 12 nmoles of RPPGF) was derivatized to 
form the DMPO-N-TFA-Q-ME derivative for DIP-MS analysis, with HPLC 
isolation of the sequential derivatives. The reverse phase ion 
pairing HPLC chromatogram for the isolation of DMPO-RPPGF is pre-
sented in Figure 3.43. The unreacted peptide eluted from this 
gradient system at 25% acetonitrile concentration, and the DMPO 
derivative eluted at 28% acetonitrile (these concentrations and 
those below are corrected for the void volume of the system). The 
broad peak eluting at 41% acetonitrile represents a peptide-related 
reaction by-product. The formation of the DMPO derivative was 
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Figure 3.43. Reverse phase ion pa1r1ng HPLC chromatogram (TFA 
system) of the DMPO-derivatized B3 fraction from the spiked urine 
sample. The indicated region of the chromatogram, corresponding to 
RPPGF-DMPO, was collected. 
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maximized and that of the by-product was minimized using the modi-
fied acetylacetone condensation procedure. The indicated region of 
the chromatogram was collected, dried, treated with 3 M methanolic 
HCl and chromatographed by reverse phase ion pairing HPLC. Fig-
ure 3.44 presents the resulting chromatogram. RPPGF-DMPO-O-ME 
eluted at 31% acetonitrile on this HPLC system, and the indicated 
region of the chromatogram was collected and dried. After tri-
fluoroacetylation, the sample was chromatographed by normal phase 
HPLC using a chloroform-methanol gradient system. The resulting 
chromatogram is presented in Figure 3.45. The downward baseline 
drift evident in this chromatogram is due to the increased UV 
transparancy of the solvent system as the methanol concentration 
increases. On this system, RPPGF-DMPO-N-TFA-Q-ME eluted at 
15% methanol in chloroform, and the indicated region of the chrom-
atogram was collected. 
The isolated derivative of fraction B3 from the spiked human 
urine sample was analyzed by DIP-MS-SIM under low (R=1,900-2,300) 
and high (R=15,OOO) resolution conditions, monitoring m/z 746, the 
molecular ion of the sought derivative of RPPGF. The resultant 
DIP-MS-SIM profiles are presented in Figures 3.46 and 3.47. Both of 
these analyses exhibit a single peak consistent with the presence of 
the RPPGF derivative. The sample was next analyzed by the more 
molecularly specific technique of DIP-CAD-SRM-MS, with the instru-
ment set to monitor the formation of an m/z 429 ion from an m/z 746 
precursor ion in the first field free region of the mass 
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Figure 3.44. Reverse phase ion pairing HPLC chromatogram (TFA 
system) of the DMPO-derivatized and methyl-esterified B3 fraction 
from the spiked urine sample. The indicated region of the chromato-
gram, corresponding to RPPGF-DMPO-O-ME, was collected. 
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Figure 3.45. Normal phase HPLC chromatogram of the DMPO-deriva-
tized, methyl-esterified and trifluoroacetylated B3 fraction from 
the spiked urine sample. The indicated region of the chromatogram) 
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Figure 3.46. Low resolution (R=1,900-2,300) direct insertion probe 
selected ion monitoring trace (monitoring m/z 746) of the dimethyl-
pyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the 
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Figure 3.47. High resolution (R=14-1S,OOO) direct insertion probe 
selected ion monitoring trace (monitoring m/z 746) of the dimethyl-
pyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the 
B3 fraction isolated from spiked human urine. 
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spectrometer. Figure 3.48 presents the resultant profile. Again, a 
single peak consistent with RPPGF is observed. The sample was then 
analyzed by repetitive scanning DIP-MS, yielding the electron impact 
mass spectrum presented in Figure 3.49, which is virtually identical 
to that of the standard material in Figure 3.39. As a final analy-
sis, roughly equal quantities of the derivatized B3 fraction and 
derivatized standard peptide were mixed in a DIP sample vial and 
analyzed by DIP-MS under high resolution (R=15,OOO) 
conditions, scanning the molecular ion region of the mass spectrum 
in raw data acquisition mode. The resultant peak profiles are 
presented in Figure 3.50. The molecular ion and the higher mass 
isotope peaks appear as singlets, indicating that the elemental 
composition of the derivatized standard peptide and the derivatized 
B3 fraction are indistinguishable at this resolution. Collectively, 
the data presented in Figures 3.46 through 3.50 unambiguously 
identify the presence of the pentapeptide RPPGF in the B3 fraction 




Figure 3.48. Direct insertion probe collisionally activated disso-
ciation linked field selected reaction monitoring mass spectrometric 
analysis of the dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl 
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Figure 3.49. Electron impact mass spectrum of the dimethylpyrimi-
dylornithyl-N-trifluoroacetyl-O-methyl ester derivative of the B3 
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Figure 3.50. High resolution (R=14-15,OOO) scan of the region of 
the mass spectrum corresponding to the molecular ion of the dimeth-
ylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester derivative of 
RPPGF. The sample was a mixture of roughly equal quantities of the 
derivatized B3 fraction and derivatized authentic RPPGF. 
CHAPTER IV 
DISCUSSION 
A. Polyaminoalcohol derivatives. 
During the past thirty years, various forms of polyaminoalcohol 
derivatives have been used for determining the amino acid sequence 
of small peptides by gas chromatography-mass spectrometry. These 
derivatives have generally been used for the qualitative analysis of 
high nanomole to micromole amounts of peptides, with very few claims 
of successful qualitative or quantitative applications to lower 
level peptide samples (30,65). The application of these derivatives 
to low level samples has not been restricted due to mass spectromet-
ric sensitivity limitations; rather, the problem has been inherent 
to the complex derivatization chemistry necessary for the formation 
of these derivatives. Detection limits have gradually been improved 
over the years, but the ultimate sensitivity which could theoreti-
cally be obtained with these derivatives has not yet been approached 
in practical terms. The present studies have pointed out some of 
the likely reasons for these persistent problems. These studies 
probably represent the first time that the sequential derivatives 
generated by the successive derivatization steps have been analyzed 
by direct chemical means, namely FAB-MS and, to some extent, HPLC. 
Fast atom bombardment mass spectrometry has only recently become 
generally available, and many advances in HPLC technology have been 
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made during the past decade. These factors rendered these sequen-
tial analyses possible, thus helping to identify some of the prob-
lems inherent in the most recently published version of the poly-
aminoalcohol derivatization scheme (17). 
According to Carr and co-workers (17), ethereal diazomethane 
and methanolic Hel may be used virtually interchangeably for methyl-
ating the carboxylic acid functions of peptides. However, the 
present studies demonstrated that methanolic Hel is the superior 
reagent for this purpose. Diazomethane is an extremely reactive 
reagent (63), capable of reacting with with numerous functions 
likely to be present in a peptide by a variety of mechanisms; thus 
the use of diazomethane carries considerable risk of unwanted side 
reactions. Furthermore, peptides are generally poorly soluble in 
diethyl ether, thus necessitating prolonged reaction times which in 
turn increases the risk of side reactions. Methanolic Hel, on the 
other hand, is much less reactive than diazomethane, yet is a highly 
efficient reagent for methylating carboxylic acid groups. Further-
more, peptides are generally highly soluble in this reagent, thus 
increasing the likelihood of a high overall yield of the sought 
methyl ester. 
Also in the paper published by Carr and co-workers, a procedure 
employing methyl trifluoroacetate was presented as an optimized 
means of trifluoroacetylating the amino functions of peptides. This 
procedure was found to be inefficient for the arginyl peptides 
employed in these studies. Steglich and Hinze (62) found that 
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methyl trifluoroacetate reacts with different amino acids at varying 
rates, requiring from ten minutes to forty-eight hours for complete 
reaction, depending on the amino acid. Similar variability of 
reaction efficiency with different peptides is thus hardly 
surprising. The procedures developed during the present studies 
employing MBTFA as a trifluoroacetylating reagent proved to be 
highly efficient for the peptides studied, although whether these 
procedures will be generally applicable to other peptides remains to 
be determined. 
The present studies demonstrated that employing the TBDMS group 
for derivatizing the hydroxy functions of polyaminoalcohols offers 
some significant advantages over the TMS group which has tradition-
ally been used for this purpose. The TBDMS derivatives exhibit 
hydrolytiC stability, which is not the case with TMS derivatives; 
one sample of the DMPO-N-TFE-O-TBDMS polyaminoalcohol derivative of 
RF, stored in pyridine solution at room temperature without special 
precautions_ was stable for at least five weeks without apparent 
decomposition. Under electron impact ionization conditions, the 
TBDMS derivatives give rise to a pair of ions corresponding to 
[M-15]+ and [M-57]+; this easily recognized pair clearly denotes the 
molecular weight of the derivative. This information is frequently 
not obvious from the [M-15]+ ions of TMS derivatives of polyamino-
alcohols, which are typically of low intensity and may be easily 
confused with chemical noise. The potential disadvantage of slight-
ly reduced volatility of the TBDMS group as compared to TMS was 
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found not to be prohibitive, since the TBDMS derivatives were 
sufficiently volatile for capillary GC-MS analysis of molecules as 
large as the pentapeptide RPPGF. The O-TBDMS polyaminoalcohol 
derivatives may thus represent a new class of derivatives useful for 
the amino acid sequencing of small peptides by GC-MS methods. 
The present studies have shown that the condensation of the 
guanidino groups of arginyl peptides with acetylacetone can be 
successfully incorporated into the polyaminoalcohol scheme, thus 
ensuring volatilization of the guanidino groups without the risk of 
peptide bond cleavage. This represents an improvement over the 
hydrazinolysis method traditionally employed with the polyamino-
alcohol scheme. The reaction sequence employed for forming the 
DMPO-N-TFE-O-TBDMS polyaminoalcohol derivatives is presented in 
Figure 4.1. These derivatives exhibit good volatility and excellent 
capillary gas chromatographic properties for arginyl peptides as 
large as RPPGF. Under both electron impact and fast atom bombard-
ment ionization conditions, these derivatives generate several ions 
diagnostic for arginyl residues. The overall cleavage patterns 
observed with these derivatives were typical of the polyamino-
alcohols, and thus the new derivatives generate complete amino acid 
sequence information in a fashion directly analogous to their well 
known Q-TMS counterparts. 
One of the goals of the present studies was to develop sensi-
tive and reliable means of analyzing low level samples of arginyl 
peptides. Even with the improved derivatization methodologies 
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Figure 4.1. Reaction sequence for forming dimethylpyrimidylorni-




developed during the course of these studies, the polyaminoalcohol 
derivatives were not successfully utilized for this purpose. 
Problems arose when attempting to extend the sensitivity limits of 
these derivatives for quantitative purposes. For qualitative 
applications, e.g. repetitive scanning analyses, a threshold was 
identified at around 10-20 nanomoles of peptide above which suffi-
cient derivative was generated to permit consistent qualitative 
identification of the peptides. Below this threshold derivative 
yield was quite variable, so that detection of the derivatives even 
by the highly sensitive method of capillary GC-MS-SIM was only 
sporadically successful. The criterion for high reliability in a 
quantitative method was thus not satisfied with the polyaminoalcohol 
derivatives. This judgement of poor reproducibility at low levels 
was based upon many repeated experiments, during which as little as 
20 picomoles of RPP were successfully analyzed, and during which as 
much as 20 nanomoles of the pentapeptide were not successfully 
analyzed. Sporadic results such as these were clearly unacceptable 
for a general analytical method. 
Two major areas were identified as the probable sources for the 
observed poor reproducibility with low level samples. The first of 
these was the diborane reduction reaction employed for converting 
the polyamide peptide backbone to the more volatile polyamine 
structure. For many years, lithium aluminum hydride was the reagent 
employed for this purpose. The use of diborane for the reduction, 
originally developed by Frank and Desiderio (16) and later improved 
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by Carr and co-workers, represented a significant advance for the 
polyaminoalcohol derivatives in that it permitted the derivatization 
and detection of lower level peptide samples than was possible with 
lithium aluminum hydride. However, the use of diborane still poses 
problems, to the extent that two identical low level samples treated 
identically by a single researcher can produce widely differing 
results. That the diborane reduction step was the problematic point 
in the overall sequence was demonstrable by FAB-MS. However, the 
specific nature of the problem, whether it is incomplete reduction 
of the polyamide backbone or ester groups, incomplete decomposition 
of the highly stable boroamine complexes, or a problem with the 
extraction process still remains unclear. Throughout the long 
history of the use of diborane for synthesizing secondary and 
tertiary amines from substituted amides, the nature of the series of 
reactions involved has never been rigorously elucidated. Further 
research on the nature of these reaction mechanisms could be of 
considerable benefit to future efforts to extend the sensitivity 
limits of the polyaminoalcohols. 
The second source identified as a possible cause of the ob-
served reproducibility problems with low level samples was residual 
reagents and reaction by-products which accumulate during the 
conversion of peptides to the fully derivatized polyaminoalcohols. 
The derivatization of an arginyl peptide to form the DMPO-N-TFE-Q-
TBDMS polyaminoalcohol involves treating the sample with ten succes-
sive reagents and reagent mixtures which consist of a total of 
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sixteen different chemical species. It is thus likely that the 
observed oily contaminants consisted of mixtures of trace levels of 
some of the derivatization reagents as well as by-products from the 
individual reactions. Accumulated contaminants from one reaction 
sequence could certainly have interfered with a subsequent deriva-
tization step. Furthermore, with low level samples, the total 
amount of the accumulated contaminants may have been several orders 
of magnitude higher than the analyte, so that when nanogram quanti-
ties of the fully derivatized peptides were injected onto a capil-
lary column, hundreds of micrograms of contaminants were co-
injected. Repeated injections of low level samples was observed to 
cause rapid and irreversible deterioration of capillary column 
performance, particularly with the larger peptides. This was less 
problematic with the higher level samples for qualitative analysis, 
e.g. 20-50 nanomoles. However, the observed deterioration of column 
performance further reduced the reliability of the overall methods 
for quantitative applications with low level samples. The use of 
HPLC for the isolation of the derivatives in high purity might 
obviate this problem; however, the ultimate value of such a proce-
dure would be questionable in light of the reproducibility problems 
associated with the diborane reduction reaction. 
The dimethylpyrimidylornithyl-N,O-di-TBDMS derivatives of 
arginyl peptides which were briefly explored showed considerable 
promise in terms of the amino acid sequence information generated 
and the sensitivity for capillary GC-MS-SIM applications which might 
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ultimately be obtained. The reaction sequence employed for forming 
these derivatives is presented in Figure 4.2. One obvious advantage 
offerred by these derivatives was the elimination of two major 
derivatization steps and their attendant reaction by-products. A 
second potential advantage was the elimination of a possible unfa-
vorable interaction due to the presence of both silicon and fluorine 
in the fully derivatized N-trifluoroethyl derivatives. During a 
study of propranolol metabolism (66), Walle and co-workers found 
that trifluoroacetyl derivatives partially decompose on gas 
chromatographic systems previously used with TMS derivatives, to the 
extent that entirely separate GC systems had to be used for the two 
derivative types (67). Similar results have since been obtained 
from capillary GC-MS analysis of silylated and trifluoroacetylated 
derivatives of adenosine (unpublished results from these laborato-
ries). The silicon-flourine bond is one of the strongest known 
covalent bonds (68), and thus it was speculated that the observed 
deterioration of capillary GC column performance might be related to 
an unknown but highly favored anamolous interaction between silicon-
or flourine-containing species in the accumulated contaminants and 
the derivatized peptides. Unfortunately, the reproducibility 
problems encountered with these derivatives prevented a complete 
assessment of this possibility. If reliable methodology for forming 
these derivatives can be developed in the future t these derivatives 
may prove to be very useful for both qualitative and quantitative 
applications. 
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B. Isolation procedures. 
The arginyl peptide selective extraction procedure which was 
developed during the course of these studies was a modified version 
of a procedure developed by Rose and co-workers (55). While this 
procedure was found to be workable with standard samples of arginyl 
peptides in simple aqueous buffers, it was found not to provide the 
interference-free, high yield extracts which were anticipated. The 
high levels of contaminating species in the extracts which were 
observed by HPLC were probably residual reagents and reaction 
by-products generated during the derivatization and extraction 
process. These contaminants likely contributed to the surprisingly 
low binding observed with the phenylboronic acid columns employed. 
Because of the high levels of interfering species and the low 
binding capacity, this procedure was judged to be inappropriate for 
application to complex biological samples such as urine. 
In order to develop efficient and reliable means for isolating 
bradykinin related arginyl peptides from complex matrices, advantage 
was taken of the favorable properties of silica based reverse phase 
matrices. Both low and high resolution reverse phase columns 
exhibit a high binding capacity with little risk of loss of low 
level analytes. Further advantage was taken of the shift in the 
elution position of peptides relative to non-peptide species which 
can be obtained through alternating the nature of the ion pairing 
reagent employed in successive chromatographic procedures. It was 
serendipitously discovered that water saturated with diethyl ether 
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containing heptafluorobutyric acid could elute all of the peptides 
of interest from reverse phase cartridge columns, and this formed 
the basis of one stage of selective elution. While the overall 
procedures developed were complex and time consuming, they neverthe-
less proved to be efficient means for isolating bradykinin related 
arginyl peptides from human urine, which is an especially complex 
matrix, and from which peptides are particularly difficult to 
isolate. It was reasoned that if these procedures could be success-
fully employed with the urinary matrix, they or variants of them 
could be used with practically any biological matrix, most of which 
are less complex than urine. Indeed, for simple systems such as 
cell culture supernatants, a single extraction followed by a single 
HPLC isolation step, with alternating ion pairing reagents, would 
probably prove sufficient for isolating these peptides in high 
purity for further analysis. It is anticipated that the isolation 
methods developed during these studies will be beneficial for future 
studies of bradykinin metabolism. 
c. Derivatization and DIP-MS analysis of RPPGF. 
Because the pentapeptide RPPGF was consistently the most 
difficult of the arginyl peptides studied to analyze by mass spec-
trometric means other than the relatively insensitive method of 
FAB-MS, and because this peptide is one of the more likely metab-
olites of bradykinin, efforts were directed toward developing 
sensitive, specific and reliable means of analyzing this compound. 
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The dimethylpyrimidylornithyl-N-trifluoroacetyl-O-methyl ester 
derivative of RPPGF was employed for these studies. The scheme 
employed for forming this derivative is presented in Figure 4.3. 
This derivative offered a significant advantage over the polyamino-
alcohol approach in the simpler derivatization chemistry necessary 
for its formation. In particular, the use of this derivative 
avoided the diborane reduction stept which was identified as a major 
source of unreliability at low levels with the polyaminoalcohols. 
Unfortunately, this derivative of the pentapeptide was insufficient-
ly volatile for GC-MS analysis, and thus sufferred the disadvantage 
of a loss of the molecular specificity afforded by capillary GC-MS 
methods. However, this derivative had the unexpected advantage of a 
surprisingly intense molecular ion under electron impact ionization 
conditions; this intense molecular ion proved suitable for both 
selected ion monitoring and selected reaction monitoring, and thus 
allowed a high degree of molecular specificity in the assay to be 
regained. A similarly intense molecular ion was also observed with 
the dipeptide RF as the DMPO-N-TFA-O-ME derivative, which was 
sufficiently volatile for GC-MS analysis (data not shown). Thus, 
this may be a general phenomenon with this type of derivative of 
small arginy1 peptides. 
Once again, accumulated contaminants from successive deriva-
tization reactions threatened the reliability of the overall method 
with low level samples by preventing the volatilization of the 
derivative in the mass spectrometer. With the pentapeptide, this 
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Figure 4.3. Reaction scheme for forming the dimethylpyrimidylorni-
thyl-N-trifluoroacetyl-O-methyl ester derivative of RPPGF. 
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problem was obviated through HPLC isolation of the three sequential 
derivatives. Normal phase HPLC permitted the isolation of the final 
derivative in highly pure form, so that very intense signals were 
consistently obtained from DIP-MS analysis of low level samples 
under low resolution, high resolution and selected reaction monitor-
ing conditions. Furthermore, the inclusion of three HPLC isolation 
steps in the derivatization process added an additional degree of 
molecular specificity. 
The use of HPLC also permitted further optimization of the 
individual derivatization reactions. During the acetylacetone 
condensation reaction, a peptide related reaction by-product was 
observed, the formation of which increased with the prolonged 
heating conditions recommended in the literature (38). The opti-
mized procedure developed during these studies permitted complete 
consumption of the underivatized peptide with minimal formation of 
this by-product. The trifluoroacetylation reaction was also opti-
mized to permit maximal yield of the fully derivatized peptide. The 
overall yield of the derivative using the new procedures was esti-
mated at 50-60%, as compared with around 20% with the non-optimized 
procedures, based upon HPLC analysis. 
These high-yield, high-purity derivatization methods, in 
combination with the highly sensitive techniques of DIP-MS, permit-
ted the unequivocal qualitative identification of RPPGF isolated 
from spiked human urine at the 12 nanomole level (one third of a 35 
nanomole sample). These overall methods should be readily 




The analysis of bradykinin metabolites could ultimately prove 
to be a powerful means of evaluating the activity of the kallikrein-
kinin system. From enzymatic and other studies, N-terminal frag-
ments of bradykinin are likely to be significant metabolites, and 
may be useful for quantitating the flux of bradykinin through the 
kallikrein-kinin-degradation system. The studies described here 
have focussed on developing means for isolating and analyzing the 
N-terminal tri- through pentapeptide fragments of bradykinin with 
high sensitivity, molecular specificity and reliability. Efficient 
but time consuming means for isolating all three of these compounds 
have been developed. The developed mass spectrometric analytical 
methodology was most highly refined with the pentapeptide RPPGF 
during these studies, but the new methods should be readily extend-
able to the shorter N-terminal peptides. A relatively low level 
(spiked) sample of RPPGF was successfully isolated and unequivocally 
identified from the exceedingly complex biological matrix of human 
urine. It is hoped that the isolation and analytical techniques 
described here will facilitate the elucidation of bradykinin metabo-
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INTRODUCTION 
One of the techniques commonly employed in the separation of 
enantiomers involves the preparation of diastereomeric derivatives 
using an optically pure chiral derivatizing reagent. The diastereo-
mers are then separated by various chromatographic means, and the 
resulting elution patterns reflect the nature of the underivatized 
material. The purpose of the study presented here was to examine 
the usefulness of O-(-)-menthyl-N,N'-diisopropylisourea as a reagent 
for preparing (-)-menthyl esters of enantiomeric carboxylic acids. 
Previously used methods for the preparation of menthyl esters 
include acid catalyzed esterification using (-)-menthol (69). This 
method requires the use of dry hydrogen chloride gas and a very 
large excess of (-)-menthol. Menthyl esters have also been prepared 
by first converting the acid to the acid chloride by refluxing with 
thionyl chloride (70) or oxalyl chloride (71), followed by treatment 
of the acid chloride with (-)-menthol. While all of these methods 
produce the desired end-product, namely diastereomeric (-)-menthyl 
esters of enantiomeric acids, the derivatization procedures them-
selves are somewhat involved and require considerable care in the 
maintenance of anhydrous conditions. Among the proposed advantages 
of O-(-)-menthyIN,N'-diisopropylisQurea «-)-MDI) as a chiral 
derivatizing reagent are the simple techniques involved with its 
use, the completeness of its reaction with carboxylic acids, and the 
lack of potential racemization during derivatization. 
137 
(-)-MDI is an adduct of (-)-menthol and N,N'-diisopropylcarbo-
diimide, as shown in Figure 5.1. This reaction is catalyzed by 
monovalent copper. The derivatization reaction, depicted in Fig-
ure 5.2, produces the two diastereomeric esters and N,N'-diisopro-
pylurea. Tertiary amines catalyze the derivatizationj triethylamine 
was used as the catalyst in these studies. 
Naphthoxylactic acid (2-hydroxy-3-(1-naphthoxy)propanoic acid; 
NLA), a major urinary metabolite of the a-adrenergic antagonist 
propranolol, and mandelic acid were used as test samples for the 
(-)-MDI reagent. The structures of these compounds are shown in 
Figure 5.3. Both of these acids have one chiral center. The 
diastereomeric derivatives were analyzed by capillary gas chrom-
atography (GC) and capillary gas chromatography-mass spectrometry 
(GC-MS). 
+ 
N.N' -diisopropylcarbodiimide (-)-menthol 
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Figure 5.3. Structures of naphthoxylactic acid, propranolol and 
mandelic acid. The asterisks (*) indicate chiral centers. 
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MATERIALS AND METHODS 
Synthesis of O-(-)-menthyl-N,NI-diisopropylisourea. 
(-)-Menthol (7.8 g, 0.050 mol; Mallinkrodt, New York, NY, USA) 
and N,N'-diisopropylcarbodiimide (6.3 g, 0.050 mol; Aldrich, Milwau-
kee, WI, USA) were dissolved in 25 ml tetrahydrofuran (Aldrich). 
Copper(I) chloride (10 mgj Fisher, Fair Lawn, NJ, USA) was added, 
and the mixture was stirred at room temperature overnight. The 
mixture was then evaporated in vacuo to 8 ml and chromatographed on 
a 250 g Al203 (W200 Basic, Woelm, Eschwege, GFR) column eluting with 
250 ml tetrahydrofuran. The tetrahydrofuran was removed by evapora-
tion in vacuo, yielding 5.86 g of (-)-MDI (41.6% of theoretical) as 
a pale yellow liquid. No appreciable decomposition of (-)-MDI was 
detected four years after synthesis. 
Other reagents. 
(±)-Naphthoxylactic acid was prepared in these laboratories by 
a procedure analogous to that reported by Nelson and Bartols (72). 
Racemic mandelic acid was obtained from Chem Service (Westchester, 
PA, USA); (-)-mandelic acid and (+)- mandelic acid were obtained 
from Aldrich, triethylamine from Eastman Kodak (Rochester, NY, USA), 
and ethyl acetate from Fisher. All solvents were ACS reagent grade 




Capillary GC analyses were performed using a Varian 3700 gas 
chromatograph equipped with a split injector and a flame ionization 
detector. The column was a Grade A 60 m x 0.25 mm I.D. SP-2100 wall 
coated open tubular (WeDT) glass capillary obtained from J&W Scien-
tific (Orangeville, CA, USA). The straightened capillary ends were 
deactivated with Carbowax 20M. 
Capillary GC-MS analyses were performed using the same gas 
chromatograph and column interfaced through an open split interface 
to a Finnigan MAT 212 mass spectrometer with a Spectrosystem SS200 
data system. 
Derivatization of enantiomeric acids. 
A 1 mg amount of each sample acid was dissolved in 400 ~1 of a 
solution of tetrahydrofuran-triethylamine (9:1; v/v); 10 ~l of 
(-)-MDI were added, and the reaction mixture was capped tightly in a 
vial and heated at 100 °C for 16 hours. The completeness of reac-
tion was monitored by forming the methyl ester of any unreacted acid 
by derivatization with diazomethane in diethyl ether followed by 
capillary GC analysis. No methyl ester peaks were observed after 
16 h heating with triethylamine as a catalyst. 
Capillary GC-MS resolution of diastereomers. 
The diastereomeric menthyl naphthoxylactates were resolved 
under the following conditions: injector temperature 260°C; split 
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ratio 1:350; column temperature programmed from 225°C to 240 °C at 
a rate of 0.2 °C/min; average linear velocity 21-22 cm/sec; open 
split interface temperature 260°C; ionization energy 70 eVe The 
conditions for the resolution of the diastereomeric menthyl mandel-
ates were identical except that the injector temperature was 200°C 
and the column temperature was programmed from 165 °C to 180°C at 
0.3 °C/min. Both analyses were complete before the final column 
temperature was reached. During both analyses the mass spectrometer 
was scanned from 45 to 400 amu at a rate of 3 sec/decade with an 
inters can time of 1 sec. 
Determination of elution order. 
Menthyl mandelates. R-(-)-Mandelic acid and S-(+)-mandelic 
acid were separately derivatized. (In the Cahn-Ingold-Prelog system 
of chiral notation, used here for the purposes of consistency, 
D-(-)-mandelic acid has the R configuration.) Aliquots of the two 
solutions were mixed in a 4:1 (v/v) ratio (S:R and R:S) and analyzed 
by capillary Ge. Elution order was determined based upon the 
retention times of the separately derivatized Rand S standards and 
the relative peak intensities of the two mixtures. 
Menthyl naphthoxylactates. Because of the unavailability of 
optically pure R- and S- naphthoxylactic acid, and because NLA is a 
major urinary metabolite of propranolol, R-naphthoxylactic acid was 
extracted from the urine of a rat dosed with S-(-)-propranolol. The 
sample was a 24-hour urine collection from a male Sprague-Dawley rat 
144 
injected intraperitoneally with 10 mg/kg of S-(-)-propranolol 
hydrochloride (Ayerst Labs., New York, NY, USA). The total urine 
volume was 14 mI. A 2 ml aliquot was adjusted to pH 1.5 with 6 N 
hydrochloric acid and extracted with 2 x 5 ml of ethyl acetate. The 
combined organic phases were evaporated to dryness under a stream of 
nitrogen; the residue was derivatized using 90 ~l of tetrahydro-
furan-triethylamine (9:1) and 10 ~l of (-)-MDI. A 6 ~l aliquot of 
this solution was mixed with 6 ~l of previously derivatized racemic 
NLA of comparable concentration. The resulting mixture was analyzed 
by selected ion monitoring (m/z 370, the molecular ion) capillary 
GC-MS. The elution order was determined by comparing the relative 
peak intensities of derivatized racemic NLA with and without the 
added derivatized urinary R-NLA. 
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RESULTS 
(-)-MDI was found to react to completion with carboxylic acids 
to form menthyl esters after 16 h heating in tetrahydrofuran with 
triethylamine as a catalyst. 
The retention behavior of the diastereomeric menthyl naphthoxy-
lactates and menthyl mandelates from capillary GC-MS analysis is 
presented in Table 5-I. The retention times presented are adjusted 
for the void volume of the system. Exemplary chromatograms from the 
two analyses are presented in Figures 5.4 and 5.5. Figure 5.4 is a 
retrospective single ion plot of the molecular ion (m/z 370) of 
menthyl naphthoxylactate. No molecular ion was observed for the 
menthyl mandelates; the plot presented in Figure 5.S is a retrospec-
+ tive plot of m/z 107, corresponding to the [(C6HS)e(OH)H] fragment 
of menthyl mandelate. Both sets of diastereomers were resolvable on 
an SP2100 weOT capillary column with slight peak overlap. Baseline 
separation was obtainable under isothermal column conditions (225 °C 
for the menthyl naphthoxylactates and 170 °C for the menthyl mandel-
ates) with some sacrifice in analysis time and peak broadening. 
The elution order of the menthyl mandelates was determined by 
comparing the retention times of the separately derivatized optical-
ly pure mandelic acid enantiomers, and by comparing the relative 
peak intensities of 4:1 (v/v) mixtures of the separately derivatized 
enantiomers. Under the conditions of the analyses, (-)-menthyl-
R-(-)-mandelate eluted with a peak maximum at 40.5 min (adjusted 
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TABLE 5-I 
RETENTION BEHAVIOR OF THE DIASTEREOMERIC MENTHYL NAPHTHOXYLACTATES 
AND MENTHYL MANDELATES ON AN SP2100 weDT CAPILLARY COLUMN 
Adjusted 
retention Carboxylic 
Column time* acid 
Analysis temperature (min, ± 0.1) enantiomer 
Menthyl 225-240 °C 51.2 R-(-) .... .I,. 
An 
naphthoxy- at 0.2 °C/min 53.7 s-(+) 
lactates 
Menthyl 165-180 °C 40.5 R-(-) 
*** mandelates at 0.3 °C/min 42.6 s-(+) 
* The elution time of a non-retained compound (butane) was subtract-
ed from the absolute retention times to obtain the adjusted reten-
tion times. 
** Determined from the data presented in Table 5-11. 
*** Determined from chromatograms of derivatized optically pure 
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Figure 5.4. Capillary GC-MS chromatogram of the diastereomeric 
menthyl naphthoxylactates. A 3 ~l sample was injected (7-8 ~g) at a 
split ratio of 1:350. The chromatogram is a ,retrospective single 
ion plot of the molecular ion (m/z 370). 
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Figure 5.5. Capillary GC-MS chromat~gram of the diastereomeric 
menthyl mandelates, as a retrospective single ion plot of the 
[{C6H5)C{OH)H]+ fragment (m/z 107) of menthyl mandelate. The sample 
size was 3 ~l (7-8 ~g) injected with a split ratio of 1:350. 
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retention time), and (-)-menthyl-S-(+)-mandelate eluted at 42.6 min. 
These retention times were reproducible to within ± 0.1 min. The 
relative peak intensities of the two 4:1 mixtures were consistent 
with the above elution order. 
In order to determine the order of elution of the menthyl 
naphthoxylactates, R-naphthoxylactic acid (R-NLA) was extracted from 
the urine of a rat dosed with S-(-)-propranolol. The shift in the 
notation of the absolute configuration derives from the shift in 
priorities in the Cahn-Ingold-Prelog system of notation. It is 
assumed that the chiral center of the a-blocking side chain of 
propranolol remains unaltered during metabolism to NLA. The ex-
tracted R-NLA was derivatized and mixed with derivatized racemic 
NLA. Table 5-II presents the relative peak intensities of this 
mixture and those of derivatized racemic NLA alone (from selected 
ion monitoring capillary GC-MS, monitoring m/z 370). From the 
results of the work of Nelson and Bartols (72), R-NLA is the nega-
tive rotating isomer. (-)-Menthyl-R-(-)-naphthoxylactate was found 
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O-(-)-menthyl-N,N'-diisopropylisourea has been synthesized and 
found to be useful for the preparation of diastereomeric (-)-rnenthyl 
esters of enantiomeric acids. (-)-Menthy1 esters (from (-)-rnenthol) 
have been used in the past in the diastereomeric separation of 
lactic and glyceric acids (69), acyclic isoprenoid acids (70), 
phytanic (73) and pristanic (74) acids, and chrysanthemic acids 
(75). The techniques involved with the use of (-)-MDI are relative-
ly simple, with the minor disadvantage of the requirement of over-
night heating in order to effect completeness of reaction. While 
this study has demonstrated the applicability of (-)-MDI to analyti-
cal samples, it could be useful on a preparative scale as well. For 
instance, a large quantity of a racemic acid could be treated with 
(-)-MDI, and the resulting diastereorners resolved by preparative 
high performance liquid chromatography. The separate esters could 
then be hydrolyzed and the optically pure enantiomers isolated. 
Such a procedure may offer advantages over repeated fractional 
crystallization in terms of yield, purity, or both. 
The determination of the order of elution of the menthyl 
mandelates was straightforward due to the availability of optically 
pure standards and the extremely reproducible retention times 
obtainable from capillary GC techniques. While the determination of 
the elution order of the menthyl naphthoxylactates was indirect, it 
afforded a further demonstration of the usefulness of (-)-MDI in its 
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application to the concentration levels of samples obtained from 
biological fluids. (-)-MDI thus has a wide range of potential 
applications as an analytical tool, and could be useful for prepara-
tive work as well. 
CHAPTER VI 
RESOLUTION OF THE SEVEN ISOMERIC RING-HYDROXYLATED PROPRANOLOLS AS 
tert.-BUTYLDIMETHYLSILYL DERIVATIVES BY CAPILLARY GAS CHROMATO-
GRAPHY-MASS SPECTROMETRY 
Kevin D. Ballard, Daniel R. Knapp, John E. Oatis, Jr. and Thomas 
Walle 
Department of Pharmacology, Medical University of South Carolina, 
Charleston, SC 29425 
As published: J. Chromatogr. 277; 333-339, 1983. 
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INTRODUCTION 
Three previously unknown ring-hydroxylated metabolites of the 
~-adrenergic antagonist drug propranolol were recently identified by 
Walle and co-workers (66). In rats and in man, 2-hydroxypropranolol 
(2-HO-P), 5-HO-P, and 7-HO-P were found, as well as the previously 
known 4-HO-P (76-80), which is the major monohydroxylated urinary 
metabolite of propranolol in both species, and the only hydroxyl-
ation product identified in the dog. Briefly, these compounds were 
identified in the following fashion. Urine samples were treated 
enzymatically to hydrolyze glucuronide conjugates; then the monohy-
droxypropranolols were extracted and analyzed as trimethylsilyl 
(TMS) and trifluoroacetyl (TFA) derivatives by gas chromatography 
(GC) and gas chromatography-mass spectrometry (GC-MS) using packed 
column techniques (3% OV-1). Identification of the isomers was 
based upon comparison of retention times and mass spectra with those 
of derivatized synthetic monohydroxypropranolols (66,81). Two 
derivatization techniques were employed because, under the condi-
tions of the analyses, 2-HO-P and 8-HO-P were unresolved as TMS 
derivatives, and 4-HO-P and 5-HO-P were unresolved as TFA deriva-
tives. Another complication encountered was that as TFA derivatives 
the propranolol peak overlapped with the 2-HO-P peak, necessitating 
the use of selected ion monitoring to distinguish these two com-
pounds. Furthermore, since TFA derivatives partially decompose on 
columns previously used with TMS derivatives, separate columns had 
to be used for the two types of derivatives. 
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The purpose of the work presented here was to develop a simpler 
technique for separating and identifying the seven isomeric ring-hy-
droxylated propranolols in order to facilitate future studies with 
these compounds. Such a technique has been developed, using a 
relatively new silylating reagent, N-methyl-N-(tert.-butyldimethyl-
silyl)trifluoroacetamide (MTBSTFA), which produces volatile tert.-
butyldimethylsilyl (TBDMS) derivatives of aliphatic and aromatic 
hydroxy groups (46), yielding mono-derivatized propranolol (TBDMS-P) 
and di-derivatized hydroxypropranolols (TBDMS-HO-P), the structures 
of which are presented in Figure 6.1. 
When pyridine is used as a solvent for the derivatization, 
secondary amines are derivatized very slowly by MTBSTFA (46); and, 
with the TBDMS group attached to the aliphatic oxygen which occurs 
far more rapidly in pyridine (46), derivatization of the secondary 
amine group is further sterically hindered. No tri-derivatized 
hydroxypropranolols were observed during the course of this study. 
(It may be possible to produce the tri-TBDMS derivatives with 
acetonitrile as the solvent (45,46,59b) but these derivatives would 
be expected to be less volatile than the di-TBDMS derivatives.) 
Separations were carried out using glass capillary GC-MS. The 
applicibility of the method was demonstrated by analysis of a urine 
sample from a rat dosed with (±)-propranolool and identification of 
the ring-hydroxylated metabolites. 
H H 
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Figure 6.1. Structures of ring-hydroxylated propranolol, TBDMS-
hydroxypropranolol and TBDMS-propranolol. 
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MATERIALS AND METHODS 
Chemicals. 
(±)-Propranolol hydrochloride was obtained from Sigma (St. 
Louis, MO). 2-HO-P and 4- through 8-HO-P were synthesized as their 
hydrochloride salts as previously described by Oatis and co-workers 
(81); 3-HO-P (the least stable isomer) was freshly synthesized as 
the free base according to the previously described procedure (81). 
N-methyl-N-(tert.-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) 
containing 1% tert.-butyldimethylsilylchlorosilane was obtained from 
Regis Chemical (Morton Grove, IL), and pyridine from Fisher (Fair 
Lawn, NJ). 
Equipment. 
Capillary GC-MS analyses were performed using a Varian 3700 gas 
chromatograph equipped with a split injector. The column, a Grade 
A, 60 m x 0.25 mm I.D. wall coated open tubular (WeOT) glass capil-
lary obtained from J&W Scientific (Orangeville, CA), was interfaced 
through an open split interface to a Finnigan MAT 212 mass spec-
trometer equipped with a Spectrosystem SS200 data system. A fisher 
Recordall Series 5000 stripchart recorder was used during selected 
ion monitoring in analoque mode. 
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Preparation of TBDMS derivatives of propranolol and monohydroxypro-
pranolols. 
A 1-1.5 mg sample of each compound was dissolved in 200 ~l of 
pyridine; 20 ~l of MTBSTFA were added, and the reaction mixture was 
tightly capped and heated at 100 °C for 2 h. Derivatization of 
8-HO-P is apparently sterically hindered, and requires 1-2 h heating 
to drive it to the di-derivatized product. The other compounds were 
more readily derivatized, but all of the individual samples were 
treated identically. A mixture of propranolol and the seven monohy-
droxypropranolols (1-1.5 mg of each) was similarly derivatized using 
100 ~l of pyridine and 120 ~l of MTBSTFA; this mixture required 
heating for 16 h at 100°C to complete the derivatization of 8-HO-P. 
The derivatives were stable in solution for at least two weeks. 
Biological sample. 
The hydroxypropranolol metabolites from a 2 ml aliquot of a 
24 hour urine collection (total urine volume was 26 ml) from a male 
Sprague-Dawley rat injected intraperitoneally with 10 mg/kg (±)-pro-
pranolol were enzymatically hydrolyzed and extracted according to 
the method described by Walle and co-workers (66). The extracted 
metabolites were derivatized using 100 ~l of pyridine and 20 ~l of 
MTBSTFA with 16 h heating at 100°C. 
Capillary GC-MS resolution of propranolol and the monohydroxypro-
pranolols. 
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The TBDMS derivatives of propranolol and the seven isomeric 
monohydroxypropranolols were resolved under the following condi-
tions: injector temperature 240°C; split ratio 1:350; column 
temperature programmed from 240 to 255 °C at a rate of 0.2 °C/min; 
helium carrier gas average linear velicity 23-25 em/sec; open split 
interface temperature 260°C; line-of-sight temperature 250°C; ion 
source temperature 240 OCt ionization energy 70 eV. During the 
analyses of synthetic samples the mass spectrometer was scanned 
repetitively from 30 to 550 amu at a rate of 3 sec/decade with an 
inters can time of 1 sec. Selected ion monitoring was used as the 
detection system during the analysis of the biological sample 
because of the enhanced sensitivity of this technique. The mass 
spectrometer was set to monitor m/z 217 using a direct probe sample 
of TBDMS-derivatized 2-HO-P for calibration. All of the compounds 
eluted before the final column temperature was reached. 
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RESULTS 
The TBDMS derivatives of propranolol and the hydroxypropranolols 
(with the exception of a-HO-p) were readily prepared using MTBSTFA 
with pyridine as a solvent. 8-HO-P formed the di-derivatized 
product less rapidly than the other hydroxypropranolols, but was 
driven to completion with heating at 100°C for up to 16 h. With 
insufficient heating, two peaks were observed corresponding to mono-
and di-derivatized 8-HO-P, with the mono-derivatized product eluting 
first. With sufficient heating, only the later eluting peak was 
observed. 
Table 6-1 presents the elution order and the retention times of 
the separately derivatized synthetic compounds; the retention times 
presented have been adjusted for the viod volume of the system. A 
representative chromatogram of the results obtained when all eight 
compounds were derivatized as a mixture is presented in Figure 6.2, 
as a mass chromatogram of the sum of m/z 72, 217, and 274. Proposed 
structures of these ionic species are depicted in Figure 6.3. A 
profile essentially identical to that in Figure 6.2 was obtained for 
m/z 72 alone, and the same profile minus the propranolol peak was 
obtained for m/z 217 or 274 alone. All three of these ions are 
abundant in the mass spectra of the hydroxypropranolols, and each is 
potentially suited for selected ion monitoring. The m/z 217 and 274 
ions are more specific for the hydroxypropranolols, as the m/z 72 
ion is subject to interference from smaller molecular weight species 
likely to be present in a biological sample. Alternatively, the 
TABLE 6-1 
ELUTION ORDER OF THE TBDMS DERIVATIVES OF PROPRANOLOL AND THE 
































* The column temperature was programmed from 240 to 255°C at a rate 
of 0.2 °C/min. 
** The elution time of a non-retained compound (butane) was sub-
tracted from the absolute retention times to obtain the adjusted 
retention times. 
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Figure 6.2. Capillary GC-MS chromatogram of the TBDMS derivatives 
of propranolol and ring-hydroxylated propranolols, as a retrospec-
tive combined plot of three ionic species, m/z 72, 217 and 274 (see 
Figure 6.3). The sample size was 3 ~l (100 ~g), injected with a 











Figure 6.3. Proposed structures of the ionic species traced in 
Figure 6.2. 
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molecular ion (m/z 503) could be monitored to enhance specificity 
for the hydroxypropranolols, but with a sacrifice in sensitivity. 
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The TBDMS derivatives of propranolol and the hydroxyproprano-
loIs were well resolved on an SP2100 WeOT capillary column, with the 
exception of 5- and 6-HO-P, which were separated by only 0.5-0.6 min 
with an overall retention time of about 1 h. This degree of resolu-
tion was obtained only when care was taken to ensure that the 
initial average linear velocity was only slightly above the optimal 
average linear velocity for the carrier gas (helium), so that the 
system would approach maximum efficiency at the higher elution 
temperatures. Under a given set of flow conditions, capillary GC-MS 
retention times were reproducible to within ± 0.1 min. 
A selected ion monitoring (m/z 217) chromatogram of the TBDMS 
derivatives of the ring-hydroxylated propranolol metabolites ex-
tracted from the urine of a rat dosed with (±)-propranolol is 
presented in Figure 6.4. The retention times of the peaks observed 
from this sample were consistent with the observed retention times 
of derivatized synthetic 2-, 7-, 4-, and 5-hydroxypropranolol run on 
the same day. The species identified by these techniques, and their 
relative proportions, are consistent with the results previously 
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Figure 6.4. Selected ion monitoring (m/z 217) capillary GC-MS 
chromatogram of the ring-hydroxylated metabolites of (±)-proprano!ol 
extracted from rat urine. The sample size was 5 ~l (approximately 
10 ~g) injected with a split ratio of 1:350. Peaks are labeled in 
accordance with the retention times of derivatized synthetic com-
pounds chromatographed on the same day. 
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DISCUSSION 
Propranolol and the seven ring-hydroxylated propranolols can be 
separated and readily identified as TBDMS derivatives using capil-
lary GC-MS techniques. The identification methodology presented 
here affords significant advantages over the techniques used in the 
past (66). The TBDMS derivatives are well suited for several 
detection systems, including flame ionization (data not shown), 
repetitive scanning mass spectrometry, ans selected ion monotoring 
MS. Only one derivatization technique is employed, eliminating the 
necessity for using two separate GC columns. TBDMS-propranolol is 
well separated from the other seven compounds, so that special 
techniques for distinguishing the parent compound from one of its 
metabolites are not necessary. 
The only major problem encountered using the techniques pre-
sented here was the moderate peak overlap between the TBDMS deriva-
tives of 5- and 6-HO-P. In order to ensure reliable identification 
of these two compounds, care must be taken to ensure that the 
capillary GC system is operating at near-maximal efficiency. 
Problems concerning the identity of either or both of these two 
compounds in a mixture may be overcome by adding a small quantity of 
derivatized synthetic 5- or 6-HO-P and comparing relative peak 
heights with and without the added compound. The method presented 
here should facilitate further studies of ring oxidation metabolic 
pathways for propranolol, and should also be applicable to isomeric 
metabolites of related compounds. 
CHAPTER VII. 
QUANTITATIVE ANALYSIS OF ADENOSINE: STATISTICAL COMPARISON OF 
RADIOIMMUNOASSAY AND GAS CHROMATOGRAPHY-MASS SPECTROMETRY-SELECTED 
ION MONITORING METHODS 
K.D. Ballard, T.D. Eller, J.G. Webb, W.R. Newman, and D.R. Knapp 
Department of Pharmacology, Medical University of South Carolina, 
Charleston, SC 29425 
R.G. Knapp 
Department of Biometry, Medical University of South Carolina, 
Charleston, SC 29425 
As published: Biomed. Environ. Mass Spectrom. 13; 667-675, 1986. 
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ABSTRACT 
A new method for quantitating adenosine concentration by 
capillary gas chromatography-mass spectrometry-selected ion monitor-
ing (GC-MS-SIM) has been developed and used as a reference method 
for evaluating a newly developed radioimmunoassay (RIA) for 
adenosine. Details of the GC-MS-SIM method are presented, along 
with the comparative results and uncertainties of both methods. 
General considerations in the statistical analysis of method compar-
ison data are discussed with particular reference to studies using 
quantitative mass spectrometry as the standard method; the adeno-
sine methods are used as specific examples in this discussion. 
Simultaneous estimation of the y-intercept and slope of the least 
squares regression line relating the results of the two methods 
using the 95% joint confidence ellipse demonstrated the absence of 
either constant or proportional error between the two methods. The 
relatively small uncertainty in the GC-MS-SIM measurements had no 
significant effect on the linear regression. Random error between 
the two methods was detected, and was estimated by the coefficient 
of variation in the RIA data as ten percent of the RIA value. 
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INTRODUCTION 
In method comparison studies, analytical techniques involving 
quantitative mass spectrometry are being used with increasing 
frequency as reference methods for determining the validity of other 
quantitative analytical methods. In a 1981 review article, Garland 
and Powell (32) cited thirty-six such studies, and at least twenty-
four similar studies have appeared since that time (83-106). The 
theoretical basis for using quantitative mass spectrometric methods 
as reference or "standard" methods in such studies stems from the 
high specificity and sensitivity for the compounds of interest 
afforded by the mass spectrometer, particularly when combined with 
the specificity of high resolution chromatographic techniques such 
as capillary gas chromatography. We have developed a new capillary 
gas chromatography-mass spectrometry-selected ion monitoring 
(GC-MS-SIM) method for quantitating adenosine, and have used this 
method to evaluate a newly developed radioimmunoassay (RIA) for 
adenosine. The GC-MS-SIM method employs St,5'-dideuteroadenosine as 
a stable isotope labeled internal standard, and uses the tetra-t-
butyldimethylsilyl (tetra-TBDMS) derivatives of adenosine and its 
dideuterated analog, with selected ion monitoring of the M-S7 ions 
characteristic of TBDMS derivatives under electron impact ionization 
conditions (44,45). This chapter discusses details of the GC-MS-SIM 
method and the comparison of the results of this method with those 
obtained with the radioimmunoassay. 
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In evaluating one analytical method using another "standardtl 
method one is faced with the problem of how to compare the data in a 
statistically valid manner and how to arrive at a quantitative 
measure of the nature and magnitude of errors in the method under 
examination. The use, and misuse, of statistical techniques in 
comparisons of analytical methods have been discussed previously 
(107-111). In this paper we discuss the use of statistical tech-
niques in method comparison studies using quantitative GC-MS-SIM as 
the reference method, with application to the adenosine methods as a 
specific example. 
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MATERIALS AND METHODS 
All glassware used in these experiments was silanized. 
Chemicals. 
S',S,_[2H2J-adenosine (112) (isotopic purity estimated at 
greater than 98%) was a generous gift from Karl H. Schram (Universi-
ty of Arizona, Tucson, AZ). Unlabeled adenosine and n-dodecane were 
reagent grade from Aldrich Chemical Co. (Milwaukee, WI). Glass-
distilled water was generated in these laboratories, and Distilled-
In-Glass grade methanol and acetonitrile were obtained from Burdick 
and Jackson Laboratories, Inc. (Muskegan, MI). N-Methyl-N-t-butyl-
dimethylsilyltrifluoroacetamide (MTBSTFA) was obtained from Regis 
Chemical Co. (Morton Grove, IL). All other chemicals were reagent 
grade from commercial sources and were used without further purifi-
cation. 
Unknown samples. 
Thirty-nine unknown samples were used for comparative measure-
ments of adenosine concentration by RIA and GC-MS-SIM. Thirty-six 
of these were coronary effluent samples from Langendorf style 
perfused guinea pig hearts. The perfusing medium was a modified 
Krebs-Henseleit solution (113) (KHS), equilibrated with 95% OXY-
gen-5% carbon dioxide, and containing NaCI (127.2 mM) KCl (4.7 roM), 
CaC12 (2.5 roM), KH2P04 (1.2 mM), MgS04 (1.1 mM), NaHC03 (24.9 roM), 
sodium pyruvate (2.0 mM), and glucose (5.5 mM). Samples were taken 
under control conditions and after various pharmacological manipula-
tions including infusion of adenosine and bolus injections of 
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isoproterenol. All coronary effluent samples were collected for 30 
seconds and immediately immersed in boiling water for 5 minutes in 
order to denature any degradative enzymes released from the heart. 
The three remaining unknown samples were left ventricular 
tissue extracts. Portions of left ventricle (approximately 100 mg) 
were quickly frozen between two copper blocks precooled with dry 
ice. The frozen tissue samples were homogenized with a PolytronR 
homogenizer in 1 ml of ice cold 10 mM Tris Hel, pH 7.2. The homo-
genate was acidified with 1 ml of 14% trichloroacetic acid, then 
centrifuged. The supernatant was decanted and saved. The pellet 
was resuspended in 2 ml of 7% trichloroacetic acid, centrifuged, and 
the supernatant combined with the first. The combined supernatant 
was neutralized with sodium hydroxide prior to analysis by RIA and 
GC-MS-SIM. 
The results of the biological experiments have been published 
elsewhere (114). 
Preparation of standard samples and internal standard solution for 
GC-MS-SIM analysis. 
Standard samples ranging in concentration from 1 to 100 ng/ml 
in adenosine concentration were prepared by serial dilution in KHS. 
The initial solution from which serial dilutions were made was 
freshly prepared to four significant figures at the start of each 
analysis. An internal standard solution containing approximately 40 
ng/100 ~l dideuteroadenosine in KHS was also freshly prepared for 
each analysis. 
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Addition of internal standard. 
An aliquot (1 ml) of each standard and unknown sample was 
pipetted into a polypropylene tube (17 x 100 mm~ Elkay Products). 
For unknown samples out of the range of the standard curve according 
to previous analysis, smaller aliquots were diluted with KHS to a 
final volume of 1 ml to bring them into range. The internal stan-
dard solution (100 ~lJ 40 ng) was then added to each sample. 
Control samples included a blank sample of KHS (1 ml), to which the 
internal standard was added, and an additional 1 ml aliquot of the 
100 ng/ml adenosine standard solution, to which no internal standard 
was added. All samples were vortexed and allowed to equilibrate for 
30 minutes. 
Extraction of adenosine with reverse-phase cartridge columns. 
Because buffer salts can interfere with silylation reactions, 
all samples were desalted using reverse-phase cartridge columns. A 
R separate CIS Sep-Pak was used for each sample. The cartridge 
columns were charged with 10 ml of methanol, and washed with 10 ml 
of water. The samples were then loaded, washed with 10 ml of water 
to effect desalting, and finally eluted with 2.5 ml of 40% (v/v) 
aqueous methanol. The samples were eluted directly i~to 10 ml 
sealable ampules (Wheaton). Eluting solvent was removed by evapora-
tion under a stream of nitrogen in a boiling water bath. 
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Formation of the tetra-TBDMS derivatives of adenosine and dideutero-
adenosine. 
To each dry sample were added 100 ~l of MTBSTFA and 400 ~l of 
aceto-
nitrile. The ampules were sealed and heated for five hours in a wax 
bath maintained at 150 °C. The ampules were then opened, and the 
contents transferred to 1 ml Reacti-VialsR (Pierce). Excess deriva-
tization reagent 
and solvent were removed by evaporation under a stream of nitrogen 
in a 40°C 
water bath. The derivatized samples were redissolved with sonica-
tion in 20 ~l 
n-dodecane. 
GC-MS-SIM. 
Quantitative GC-MS analyses were performed using a Varian 3700 
gas chromatograph interfaced to a Finnigan MAT 212 mass spectrometer 
equipped with a Spectrosystem 8S200 data system with selected ion 
monitoring hardware. The GC column was a 30 m DB-5 (0.259 rom i.d., 
0.25 ~m film thickness, J & W Scientific) fused silica capillary 
column, the outlet end of which was introduced directly into the ion 
source of the mass spectrometer through a heated transfer line 
maintained at 290°C. The gas chromatograph was equipped with an 
on-column injector and utilized helium carrier gas with a capillary 
head pressure of 35 psi (average linear velocity 40-45 em/sec at the 
upper GC oven temperatures). A sample, typically 3 ~l, was slowly 
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injected on-column with the GC oven at 225°C; after the solvent had 
passed through the column, the oven temperature was rapidly ramped 
to 280 °C, then programmed to 300°C at 3°C/minute. 
The mass spectrometer was operated in electron-impact mode (70 
eV ionization energy, 1 rnA emission) with the ion source at 220°C, 
-5 
and a typical source pressure of 1 x 10 torr. Mass spectral 
resolution was set at 700 with a flat-topped peak shape. Ion source 
potentials were optimized while monitoring the m/z 207 column bleed 
peak with the GC oven at 300 °C. 
The magnet was operated in current regulation mode for stabili-
ty. The magnetic field was manually set to focus m/z 666.4 at the 
nominal accelerating voltage of 3 kV; magnetic focusing was checked 
immediately prior to each sample injection in order to correct for 
any drift in magnetic field strength. 
The ion intensities at m/z 666.4 and 668.4 were monitored by 
alternating the accelerating voltage only (no magnetic jumping was 
employed). The intensity corresponding to each ion was recorded 10 
times per second, with each recorded measurement being the average 
of 16 individual measurements. This high rate of sampling was used 
in order to maximize the precision of the ion intensity area ratio 
measurements from narrow capillary GC peaks. The areas under the GC 
ion intensity profiles were measured using the standard software 
with the SS200 data system. 
176 
Data reduction 
The 666/668 ion intensity ratio measurements were converted to 
idealized mole ratios (~/y, sample to internal standard) using 
equation (1) (115): 
x (Ry - Rm) (Rx + 1) 
= (1) 
y (Rm - Rx) (Ry + 1) 
where Rx is the 666/668 ion intensity ratio for pure unlabeled 
sample, Ry is the corresponding ratio from the pure internal stan-
dard, and Rm is the ratio for each mixture. The utility of this 
equation has been discussed thoroughly in the literature (115,116). 
Standard curves were generated by plotting ~/~ calculated from the 
known samples versus the adenosine concentration. The !/I ratio was 
calculated for each unknown sample, and the adenosine concentration 
calculated from the standard curve; any necessary corrections for 
sample dilution were then applied. 
Radioimmunoassay. 
A detailed description of the new RIA for adenosine is beyond 
the scope of this manuscript. Briefly, the antiserum was raised in 
rabbits using an immunogen of 2',3'-O-disuccinyl adenosine coupled 
to bovine serum albumin with isobutyl chloroformate. Free and bound 
adenosine were separated using dextran-charcoal, with iodinated 
tyramine bound to disuccinyl adenosine used as a tracer. The 
detection limit was established at approx~ately 280 pg/ml. Speci-
ficity studies employing a series of related compounds showed 
maximum cross reactivities of 1.7% for deoxyadenosine and 0.06% for 
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adenosine monophosphate. The intraassay coefficient of variation 
averaged 3.2%, and the interassay coefficient of variation was 3-5%. 
RIA linear transformation 
The standard linear transformation for radioimmunoassay data 
was used, where the logit of BIB (binding over maximal binding) is 
m 
plotted against the logarithm of adenosine concentration (117). 
Statistics 
The lines of best fit for the linearly transformed standard 
curves from both GC-MS-SIM and RIA analyses were calculated using 
classical least squares linear regression techniques (118). For 
both standard curves, 95% confidence limits on X values calculated 
from measured Y values were determined using the 95% inverse toler-
ance limits for the entire regression line as described by Williams 
(118). 
Several statistical calculations were employed in comparing the 
RIA and GC-MS-SIM quantitative results. The y-intercept and the 
slope of the line relating [AJ R1A (y) and [A]GCMS (X) were calculat-
ed using classical least squares procedures (118), as were the 
independent tests for the significance of the y-intercept and the 
slope. The 95% joint confidence ellipse for testing the hypothesis 
that the y-intercept and slope are simultaneously a and 1 respec-
tively was generated as described by Neter and Wasserman (119). 
Deming's method for determining a linear equation for data involving 
errors in both ordinate and abscissa was employed in the manner 
described by Cornbleet and Gochman (111). 
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RESULTS AND DISCUSSION 
Mass spectra of the tetra-TBDMS derivatives of adenosine and 
S',S'-dideuteroadenosine are presented in Figure 7.1. The fragmen-
tation patterns in these spectra are very similar to those described 
for trimethylsilyl derivatives of nucleosides by Pang and co-workers 
(120). The molecular ion regions of both spectra are of very low 
intensity, while the M-S7 ions, characteristic of TBDMS derivatives 
(44,4S), are prominent in both. The molecular ions and fragment 
ions involving the ribose (sugar) moiety (S) differ by two m/z units 
between the two spectra, while fragments involving the base (B) but 
not the ribose are identical. The M-S7+2 ions are also prominent in 
these spectra; since m/z 666 and 668 were the ions monitored for 
quantitative GC-MS analysis, the presence of an intense m/z 668 peak 
in the unlabeled spectrum presents an ion overlap problem (121), as 
will be discussed below. The base peak in these spectra, m/z 73, 
was identified as the rearrangement ion [(CH3)3Si]+ by measuring its 
exact mass by high resolution (R=10,000) direct probe mass spectro-
metry with peak matching against the m/z 69 ion of perfluorokerosene 
(theoretical exact mass 73.0474 amu; experimental 73.0470 amu). 
Representative GC-MS-SIM traces at m/z 666.4 and 668.4 from a 
perfusate sample are presented in Figure 7.2. The tetra-TBDMS 
derivative of adenosine has excellent chromatographic properties on 
a fused silica DB-S capillary GC column, and retention times were 
reproducible to within ± 3 seconds. The SIM traces were entirely 
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Figure 7.1. Averaged, background subtracted repetitive scanning 
mass spectra of the tetra-TBDMS derivatives of adenosine (A) and 
5',5'-dideuteroadenosine (B). 
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Figure 7.2. Capillary GC-MS-SIM traces of m/z 666.4 and 668.4 from 
a perfusate sample (76.4 ± 1.9 ng/ml, 6-8 ng injected on-column). 
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A plot of the 666/668 ion intensity ratio versus the adenosine 
concentration from the standard curve data was hyperbolic, asymptot-
ically approaching the ratio for pure derivatized unlabeled adeno-
sine as the relative concentration of internal standard decreased. 
This phenomenon occurred because of the presence of the m/z 668 peak 
in the mass spectrum of the unlabeled material (Figure 7.1A), and 
necessitated the use of a linear transformation on the standard 
curve data, which was performed using equation (1) as recommended by 
Colby and McCaman (115). The standard curves of the transformed 
data (Figure 7.3) were linear over the 1-100 ng/ml adenosine concen-
tration range, with a typical correlation coefficient of 0.9998. At 
higher levels of adenosine concentration (e.g. 500 ng/ml), propagat-
ed errors reached an unacceptable level (115), thus limiting the 
upper end of the standard curve to 100 ng/ml with 40 ng/ml internal 
standard. The lower end of the range was dictated by the anticipat-
ed lowest concentration of the samples to be analyzed (5-10 ng/ml), 
and was not due to sensitivity limitations. The GC-MS-SIM methodol-
ogy described here should be useful in the picogram per milliliter 
range, with an appropriate reduction in the amount of added internal 
standard. 
The derivatization reaction was not complete under the condi-
tions employed, with approximately 30-35% of the adenosine driven to 
the tetra-derivatized form. However, variations in extraction and 
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Figure 7.3. Linearly transformed standard curve from capillary 
GC-MS-SIM analysis. The ratio x/~ is the transformed 666/668 ion 
intensity ratio. The solid line represents the estimated least 
squares regression line, and the dashed lines represent the 95% 
inverse tolerance limits for the estimated regression line. 
the stable isotope labeled internal standard, as evidenced by the 
excellent linearity of the transformed standard curve. 
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Also shown in Figure 7.3 are the 95% inverse tolerance limits 
for the GC-MS-SIM standard curve regression line. These were used 
to place confidence intervals on calculated X values (adenosine 
concentration) from measured, transformed Y values (~/y, the trans-
formed 666/668 ion intensity ratio). While actually hyperbolic, 
these two lines are approximately parallel to the regression line, 
giving a 95% confidence band of ± 2 ng/ml across the entire range of 
the standard curve. This establishes the lower limit of quantita-
tion with this standard curve at around 5 ng/ml, since at the lower 
standard concentration, 1 ng/ml, the uncertainty is larger than the 
known value. For concentrations below 5 ng/ml, a new standard curve 
covering a lower range of concentrations would be needed. The 
lowest level of adenosine concentration in an unknown sample mea-
sured in these analyses was 5.0 ± 2.1 ng/ml. 
Figure 7.4, a typical linearly transformed standard curve from 
RIA analysis, shows the 95% inverse tolerance limits on the loga-
rithm of adenosine concentration. By definition, these tolerance 
limits are hyperbolic, and thus automatically incorporate the 
heteroscedacity (nonconstant variance) inherent in RIA measurements. 
However, both the RIA and GC-MS standard curves exhibited excellent 
linearity, and the hyperbolic nature of the tolerance limits, 
although present, is not visually apparent in either standard curve. 
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Figure 7.4. Linearly transformed standard curve for the radio-
immunoassay for adenosine; B/Bm is the ratio of binding (B) to 
maximal binding (Bm). The solid line represents the estimated least 
squares regression line, and the dashed lines represent the 9570 
inverse tolerance limits for the estimated regression line. 
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equation to an unknown sample yielded 95% confidence limits for the 
logarithm of adenosine concentration~ which, when exponentiated, 
generated a confidence interval for adenosine concentration. This 
confidence interval is asymmetric due to the logarithmic nature of 
the standard curve. 
The comparative results between RIA and GC-MS-SIM analyses are 
plotted in Figure 7.5, with Figure 7.SA covering the entire range of 
observations (5 to 3000 ng/ml), and Figure 7.SB expanded to show the 
cluster of values in the 5-300 ng/ml range. (The higher concentra-
tions were measured by GC-MS by diluting the sample into the 1-100 
ng/ml range.) The vertical bars indicate the 95% confidence limits 
on [A] for each sample from RIA analysis, and the horizontal bars 
show the corresponding 95% confidence limits for fA] from GC-MS-SIM 
analysis. The estimated regression line relating [A]RIA (Y) and 
[A]GCMS (X) obtained by classical least squares analysis is shown as 
the solid line. The ideal relationship between the two methods 
occurs when identical results are obtained with both methods, and is 
represented mathematically by the functional relationship Y=X or 
[A]RIA = [A]GCMS· This relationship occurs when the regression line 
relating [A]RIA and [A]GCMS has simulatneously a y-intercept and 
slope of zero and one~ respectively. This ideal line of identity is 
represented by the dashed line in Figure 7.5. In order to investi-
gate the agreement of the results of the two methods, it is neces-
sary to test the hypothesis that the true (population) y-intercept 
and slope of the estimated regression line relating [A]RIA and 
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Figure 7.5. Plot of the quantitative measurements of adenosine 
concentration obtained by radioimmunoassay versus those obtained by 
capillary GC-MS-SIM. Vertical and horizontal bars represent 95% 
confidence limits for individual samples from RIA and GC-MS-SIM 
respectively. The concentration ranges displayed are 5-3000 ng/ml 
(A) and 5-300 ng/ml (B). The solid line represents the estimated 
least squares regression line (correlation coefficient r = 0.9888), 
and the dashed line represents the line of identity (Y=X). The 
points indicated with an asterisk were ventricular tissue extracts. 
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[A]GCMS do not deviate significantly, in the statistical sense, from 
zero and one, respectively. It is common practice to test this 
hypothesis by breaking it into two hypotheses and testing them 
separately and independently, i.e. testing the hypothesis that the 
y-intercept is equal to zero, and then testing the hypothesis that 
the slope is equal to one. These tests are performed by calculating 
confidence intervals (e.g. 95%) for each of the two parameters and 
determining whether or not each confidence interval overlaps with 
its ideal value. For the regression line presented in Figure 7.5, 
the 95% confidence interval for the y-intercept is 9.3 ± 42.7, and 
that for the slope is 0.976 ± 0.049. Both of these confidence 
intervals overlap with the ideal values, and one is tempted to 
conclude at this point that the ideal relationship holds, i.e. that 
the results obtained with the RIA are not significantly different 
from those obtained by GC-MS-SIM. 
However, separate hypothesis tests for the y-intercept and 
slope do not provide assurance at the given level of significance 
(e.g. 95%) that conclusions for both the intercept and slope are 
simultaneously correct. In order to test the two hypotheses simul-
taneously, a joint confidence ellipse may be constructed which 
incorporates all simultaneous values for y-intercept and slope 
supported by the data at the chosen significance level (119, 122). 
Figure 7.6 shows the 95% joint confidence ellipse for y-intercept 
and slope constructed using the data presented in Figure 7.S. The 
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Figure 7.6. Elliptical 95% joint confidence region for simultaneous 
estimation of the y-intercept and the slope for the data presented 
in Figure 7.5. 
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y-intercept and slope, shown as the point (9.3, 0.976). The conclu-
sion that the y-intercept and slope are simultaneously not signifi-
cantly different from zero and one, respectively, is supported by 
the data if the point (O,l) is included within the boundaries of the 
ellipse, as it is in Figure 7.6. This suggests that that observed 
deviations of the y-intercept and slope from their hypothesized 
values of zero and one are likely to be due to random chance. If 
the point (0,1) had fallen outside the boundaries of the 95% joint 
confidence ellipse, then it would be very unlikely that the observed 
deviations of the y-intercept and slope from their ideal values were 
due to random chance, and it would be concluded that either the 
y-intercept or slope (or both) differs significantly from the ideal 
relationship. Note that it is possible for the values calculated 
from a least squares regression analysis to pass both independent 
tests while not passing the simultaneous test. The data presented 
in Figure 7.5 pass all of these. 
The statistical analysis described above is based upon the 
techniques of classical least squares regression. In order for such 
an analysis to be strictly valid, the data analyzed should meet 
certain criteria. First, there should be no uncertainty in the 
values of the independent (X) variable, and secondly, the uncertain-
ty in the dependent (y) variable should be constant for all values 
of X (constant variance). Unfortunately, these criteria are seldom 
met in method comparison studies. Both of the methods for measuring 
adenosine concentration used in the present study incorporate 
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inherent uncertainty, as shown by the error bars in Figure 7.5. The 
uncertainty in the GC-MS-SIM measurements is small compared to that 
in the RIA measurements, which lends justification to the use of 
GC-MS-SIM as the reference method. However, the presence of a small 
uncertainty in the reference method should not be completely ig-
nored. Other authors (110,111) have recommended the use of Deming's 
method for determining the y-intercept and slope in regression 
analyses involving errors in both X and Y. For the data in this 
study, Deming's method generates a y-intercept of 9.1 and a slope of 
0.976; the close similarity between these values and those obtained 
through classical least squares regression procedures suggests that 
the relatively small uncertainty in the GC-MS-SIM measurements has a 
negligible effect on the linear regression. 
The criterion for constant variance in the Y (RIA) data is also 
not met by the data in this study. As demonstrated by the vertical 
bars in Figure 7.5, the magnitude of the uncertainty in the RIA data 
increases as the RIA value increases. On the average, this uncer-
tainty is a constant percentage of the RIA value, and the Y data in 
Figure 7.5 can thus be described as having a constant coefficient of 
variation, defined as the standard deviation of repeated measure-
ments of a single Y value divided by the mean of those repeated 
measurements. Although such repetitive measurements were not 
performed in this study, the coefficient of variation may be esti-
mated as one fourth of the magnitude of the RIA 95% confidence 
interval for a given point divided by the RIA value of the point 
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(note: the 95% confidence interval is approximately four standard 
deviations). When this calculation is performed for all of the 
points in Figure 7.5 and averaged, the coefficient of variation in 
the RIA data is estimated to be 0.1, or 10% of the RIA value. Data 
involving a constant coefficient of variation may be analyzed 
through weighted least squares regression analysis; however, 
Cornbleet and Gochman (111) have demonstrated that the classical 
procedure calculates the correct regression line even with a coeffi-
cient of variation as high as 20%, so that weighted least squares 
analysis is not required. While this description of the RIA data as 
incorporating a constant coefficient of variation must be regarded 
as an approximation, it is a reasonable one in this case due to the 
virtually parallel nature of the 95% inverse tolerance limits 
associated with the logarithmic RIA standard curve (Figure 7.4). 
Three major types of errors may occur between the results of 
two analytical methods. These are constant, proportional, and 
random errors. Westgard and Hunt (109) have demonstrated the 
utility of statistical analysis, particularly least squares regres-
sion, in determining the nature and estimating the magnitude of such 
errors in method comparison studies. From least squares linear 
regression analysis, a constant discrepancy between two methods is 
reflected in the value of the y-intercept, and a proportional error 
is measured as the deviation of the slope from the ideal value of 
one. Neither constant nor proportional error has been detected 
between the RIA and GC-MS-SIM methods in this study, since the 
y-intercept and slope have been shown to be simultaneously not 
significantly different from zero and one~ respectively. 
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The major error detected statistically between these two 
analytical methods is of the random type. Random errors may be 
measured from least squares regression analysis as the standard 
deviation of the residual error of regression (Syx). For the data 
in Figure 7.5~ Syx is calculated to be 110 ng/ml by the classical 
procedure and 108 ng/ml by Deming's procedure. Westgard and Hunt 
(109) have shown that Syx is a good estimator of random error when 
the Y data have constant variance. However~ Cornbleet and Gochman 
(111) point out that when the Y data have a constant coefficient of 
variation, rather than constant variance~ Syx is not constant, but 
increases as X and Y increase. Thus, a more reasonable estimate of 
the random error between these two analytical methods is the coeffi-
cient of variation, or ten percent of the RIA value. 
As has been pointed out (109) statistics are not a substitute 
for judgements upon the acceptability of an analytical method, but 
they can provide a basis upon which judgements can be made. The 
radioimmunoassay evaluated in this study has the advantages of 
simplicity, speed, and a broad range of quantitation, and is thus 
well suited for use with large numbers of samples. In contrast, the 
GC-MS-SIM method is labor intensive, time consuming, and has a 
restricted range of quantitation. However, the RIA measurements 
incorporate a greater uncertainty than the GC-MS-SIM measurements, 
and the utility of the RIA may be limited by this uncertainty. 
193 
Based upon the statistical analysis described in this study, the 
radioimmunoassay for adenosine will be useful in experiments where a 
random error of ten percent of the "true" value can be tolerated, 
since neither constant nor proportional errors were detected. 
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